query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_1567_ESMFold_hypothetical_protein	4n57-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4n57-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-IVa ADP complex	0.191	310	223	178	487	19	295	3.319E-10	319
LOKIASV2_1567_ESMFold_hypothetical_protein	3n4v-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3n4v-assembly2.cif.gz_B apo APH(2")-IVa form III	0.170	310	229	178	487	20	296	7.135E-10	303
LOKIASV2_1567_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	0.132	347	289	149	482	2	348	1.097E-09	295
LOKIASV2_1567_ESMFold_hypothetical_protein	4dfb-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4dfb-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	0.186	309	222	178	486	20	293	1.609E-09	286
LOKIASV2_1567_ESMFold_hypothetical_protein	3w0p-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3w0p-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (D198A), ternary complex with ADP and hygromycin B	0.138	313	239	179	491	13	290	7.796E-09	285
LOKIASV2_1567_ESMFold_hypothetical_protein	4dta-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4dta-assembly1.cif.gz_A Crystal Structure of F95M Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Adenosine	0.178	304	226	178	481	20	295	2.996E-09	283
LOKIASV2_1567_ESMFold_hypothetical_protein	3dxp-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	3dxp-assembly1.cif.gz_A-2 Crystal structure of a putative aminoglycoside phosphotransferase (reut_a1007) from ralstonia eutropha jmp134 at 2.32 A resolution	0.126	311	265	182	492	23	326	4.607E-09	269
LOKIASV2_1567_ESMFold_hypothetical_protein	3w0m-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3w0m-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia, apo form	0.151	314	236	179	492	11	289	3.991E-09	268
LOKIASV2_1567_ESMFold_hypothetical_protein	3w0q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3w0q-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (N203A), ternary complex with AMP-PNP and hygromycin B	0.133	313	240	179	491	14	291	5.318E-09	264
LOKIASV2_1567_ESMFold_hypothetical_protein	1nd4-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	1nd4-assembly1.cif.gz_B Crystal structure of aminoglycoside-3'-phosphotransferase-IIa	0.178	291	200	173	463	11	254	1.319E-08	263
LOKIASV2_1567_ESMFold_hypothetical_protein	3w0r-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3w0r-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (N202A), ternary complex with AMP-PNP and hygromycin B	0.159	304	232	179	482	13	289	6.138E-09	260
LOKIASV2_1567_ESMFold_hypothetical_protein	3tyk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3tyk-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(4)-Ia	0.145	313	237	179	491	15	292	2.129E-08	259
LOKIASV2_1567_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	0.152	306	237	180	485	15	294	5.281E-08	253
LOKIASV2_1567_ESMFold_hypothetical_protein	4dtb-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4dtb-assembly2.cif.gz_B Crystal Structure of F95Y Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Guanosine	0.171	304	228	178	481	20	295	2.029E-08	253
LOKIASV2_1567_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.151	307	234	180	486	18	294	3.121E-08	248
LOKIASV2_1567_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.170	298	232	178	475	16	295	6.708E-08	245
LOKIASV2_1567_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	0.141	306	236	182	487	23	298	7.742E-08	241
LOKIASV2_1567_ESMFold_hypothetical_protein	7w19-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7w19-assembly2.cif.gz_B Crystal Structure of Acinetobacter baumannii MPH-E	0.170	303	228	179	481	15	290	6.708E-08	238
LOKIASV2_1567_ESMFold_hypothetical_protein	2ppq-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	2ppq-assembly1.cif.gz_A-2 Crystal structure of the homoserine kinase from Agrobacterium tumefaciens	0.113	335	267	151	485	6	307	1.310E-07	237
LOKIASV2_1567_ESMFold_hypothetical_protein	3i0o-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3i0o-assembly1.cif.gz_A Crystal Structure of Spectinomycin Phosphotransferase, APH(9)-Ia, in complex with ADP and Spectinomcyin	0.168	312	256	178	489	18	326	1.598E-08	235
LOKIASV2_1567_ESMFold_hypothetical_protein	5uxb-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5uxb-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	0.142	312	233	167	478	12	284	4.361E-08	234
LOKIASV2_1567_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	2bkk-assembly2.cif.gz_C Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	0.205	278	196	174	451	14	261	6.096E-08	231
LOKIASV2_1567_ESMFold_hypothetical_protein	1l8t-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1l8t-assembly1.cif.gz_A Crystal Structure Of 3',5"-Aminoglycoside Phosphotransferase Type IIIa ADP Kanamycin A Complex	0.200	273	194	173	445	14	256	2.217E-07	231
LOKIASV2_1567_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5igw-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II - complex with GDP and clarithromycin	0.137	306	236	182	487	22	295	1.512E-07	231
LOKIASV2_1567_ESMFold_hypothetical_protein	5uxb-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5uxb-assembly2.cif.gz_B Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	0.140	300	236	179	478	17	291	8.122E-08	229
LOKIASV2_1567_ESMFold_hypothetical_protein	5iqc-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.161	305	232	178	482	18	294	1.586E-07	228
LOKIASV2_1567_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	0.196	273	182	174	446	15	241	4.766E-07	217
LOKIASV2_1567_ESMFold_hypothetical_protein	4fex-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4fex-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	0.163	264	198	182	445	18	254	3.552E-06	216
LOKIASV2_1567_ESMFold_hypothetical_protein	4r77-assembly3.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4r77-assembly3.cif.gz_A Crystal structure of choline kinase LicA from Streptococcus pneumoniae	0.163	310	222	176	485	16	281	4.766E-07	215
LOKIASV2_1567_ESMFold_hypothetical_protein	4r78-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4r78-assembly1.cif.gz_A Crystal structure of LicA in complex with AMP	0.162	337	236	149	485	4	286	8.460E-07	215
LOKIASV2_1567_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	0.175	296	224	180	475	18	289	6.053E-07	213
LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly1.cif.gz_A Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.154	281	216	165	445	1	256	1.908E-06	212
LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly6.cif.gz_F	LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.168	265	195	181	445	4	238	5.731E-06	211
LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly8.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly8.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.155	264	202	182	445	20	259	4.512E-06	208
LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.164	264	197	182	445	25	261	5.463E-06	207
LOKIASV2_1567_ESMFold_hypothetical_protein	5igh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5igh-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type I	0.133	302	236	181	482	25	297	6.987E-07	207
LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly17.cif.gz_I	LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly17.cif.gz_I Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.159	281	213	165	445	6	259	3.077E-06	206
LOKIASV2_1567_ESMFold_hypothetical_protein	4ej7-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4ej7-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound	0.163	281	210	165	445	7	258	2.934E-06	205
LOKIASV2_1567_ESMFold_hypothetical_protein	4fex-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4fex-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	0.159	264	198	182	445	18	254	9.698E-06	204
LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly9.cif.gz_F	LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.161	281	209	165	445	10	259	6.306E-06	201
LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly4.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.154	264	198	182	445	1	235	7.279E-06	197
LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.154	265	215	181	445	1	255	4.100E-06	196
LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly10.cif.gz_J	LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly10.cif.gz_J Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.175	264	194	182	445	25	260	8.009E-06	196
LOKIASV2_1567_ESMFold_hypothetical_protein	4gki-assembly6.cif.gz_F	LOKIASV2_1567_ESMFold_hypothetical_protein	4gki-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NM-PP1	0.175	264	194	182	445	19	254	1.292E-05	195
LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly7.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4few-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.168	281	206	165	445	1	249	1.292E-05	194
LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4feu-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.152	281	214	165	445	4	256	8.009E-06	193
LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly7.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.163	265	198	181	445	11	247	1.232E-05	190
LOKIASV2_1567_ESMFold_hypothetical_protein	3i0q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3i0q-assembly1.cif.gz_A Crystal Structure of the AMP-bound complex of Spectinomycin Phosphotransferase, APH(9)-Ia	0.169	309	244	178	486	17	311	9.310E-07	186
LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly18.cif.gz_K	LOKIASV2_1567_ESMFold_hypothetical_protein	4gkh-assembly18.cif.gz_K Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.160	281	211	165	445	11	262	3.206E-05	184
LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly9.cif.gz_F	LOKIASV2_1567_ESMFold_hypothetical_protein	4fev-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.162	264	197	182	445	10	245	4.700E-05	180
LOKIASV2_1567_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	0.124	313	240	170	482	12	286	1.067E-05	149
LOKIASV2_1567_ESMFold_hypothetical_protein	5cf4-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5cf4-assembly2.cif.gz_B CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE	0.125	320	253	165	484	1	290	2.294E-05	147
LOKIASV2_1567_ESMFold_hypothetical_protein	6nvl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6nvl-assembly1.cif.gz_A FGFR1 complex with N-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide	0.098	318	242	165	482	5	273	3.528E-05	145
LOKIASV2_1567_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	0.128	310	225	173	482	12	270	5.425E-05	141
LOKIASV2_1567_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7dhl-assembly1.cif.gz_A Crystal structure of FGFR3 in complex with pyrimidine derivative	0.090	315	255	168	482	6	286	5.970E-05	141
LOKIASV2_1567_ESMFold_hypothetical_protein	5tq3-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5tq3-assembly2.cif.gz_B Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin	0.130	313	244	172	484	4	284	7.954E-05	138
LOKIASV2_1567_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE	0.122	313	251	180	492	5	291	3.206E-05	138
LOKIASV2_1567_ESMFold_hypothetical_protein	2x2l-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	2x2l-assembly1.cif.gz_A-2 Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.122	327	248	156	482	4	287	6.891E-05	137
LOKIASV2_1567_ESMFold_hypothetical_protein	2b9i-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2b9i-assembly1.cif.gz_A Crystal structure of Fus3 with a docking motif from Msg5	0.123	227	132	170	396	8	159	2.389E-04	137
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqg-assembly1.cif.gz_A c-KIT T670I mutated kinase domain in complex with avapritinib	0.137	313	236	168	480	17	291	3.882E-05	136
LOKIASV2_1567_ESMFold_hypothetical_protein	5tq3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5tq3-assembly1.cif.gz_A Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin	0.131	313	241	172	484	4	281	1.010E-04	135
LOKIASV2_1567_ESMFold_hypothetical_protein	5l3a-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5l3a-assembly1.cif.gz_A Fragment-based discovery of 6-arylindazole JAK inhibitors	0.121	311	247	172	482	6	287	1.166E-04	135
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqg-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqg-assembly2.cif.gz_C c-KIT T670I mutated kinase domain in complex with avapritinib	0.133	313	243	168	480	18	298	4.700E-05	135
LOKIASV2_1567_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	0.142	229	124	174	402	32	177	1.630E-04	135
LOKIASV2_1567_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	0.137	215	119	180	394	31	169	3.340E-04	135
LOKIASV2_1567_ESMFold_hypothetical_protein	4d1s-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4d1s-assembly1.cif.gz_A Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors	0.119	312	242	173	484	6	281	1.166E-04	134
LOKIASV2_1567_ESMFold_hypothetical_protein	6in0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6in0-assembly1.cif.gz_A Crystal structure of EphA3 in complex with 18-Crown-6	0.107	307	226	180	486	9	262	1.481E-04	133
LOKIASV2_1567_ESMFold_hypothetical_protein	7uyv-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7uyv-assembly2.cif.gz_B Crystal structure of JAK3 kinase domain in complex with compound 25	0.116	311	241	172	482	6	279	1.554E-04	133
LOKIASV2_1567_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	0.099	323	243	171	493	18	288	1.412E-04	133
LOKIASV2_1567_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	0.140	231	129	171	401	47	197	4.667E-04	133
LOKIASV2_1567_ESMFold_hypothetical_protein	6vnf-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6vnf-assembly1.cif.gz_B JAK2 JH1 in complex with MA9-086	0.144	313	242	172	484	6	289	9.181E-05	132
LOKIASV2_1567_ESMFold_hypothetical_protein	6tpd-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6tpd-assembly1.cif.gz_A Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity	0.134	311	243	172	482	5	286	1.481E-04	131
LOKIASV2_1567_ESMFold_hypothetical_protein	3my0-assembly13.cif.gz_M	LOKIASV2_1567_ESMFold_hypothetical_protein	3my0-assembly13.cif.gz_M Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	0.089	221	138	180	400	9	160	1.215E-03	131
LOKIASV2_1567_ESMFold_hypothetical_protein	7uyw-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7uyw-assembly1.cif.gz_A Crystal structure of JAK2 kinase domain in complex with compound 30	0.131	313	246	172	484	5	288	8.343E-05	130
LOKIASV2_1567_ESMFold_hypothetical_protein	3kck-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3kck-assembly1.cif.gz_A A Novel Chemotype of Kinase Inhibitors	0.145	312	239	173	484	6	286	1.223E-04	129
LOKIASV2_1567_ESMFold_hypothetical_protein	3my0-assembly15.cif.gz_O	LOKIASV2_1567_ESMFold_hypothetical_protein	3my0-assembly15.cif.gz_O Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	0.096	221	139	180	400	9	163	1.104E-03	129
LOKIASV2_1567_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	0.122	225	146	172	396	1	167	2.389E-04	129
LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H	LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly8.cif.gz_H Crystal structure of EphB1	0.104	307	227	180	486	9	262	3.675E-04	128
LOKIASV2_1567_ESMFold_hypothetical_protein	5oxg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5oxg-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854	0.104	226	135	173	398	4	155	1.215E-03	128
LOKIASV2_1567_ESMFold_hypothetical_protein	6vnk-assembly4.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6vnk-assembly4.cif.gz_A JAK2 JH1 in complex with PN4-073	0.145	312	240	173	484	13	294	1.112E-04	128
LOKIASV2_1567_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	0.142	221	124	180	400	26	170	7.178E-04	128
LOKIASV2_1567_ESMFold_hypothetical_protein	7du8-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7du8-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Selpercatinib	0.147	309	223	174	482	14	276	5.172E-05	127
LOKIASV2_1567_ESMFold_hypothetical_protein	4ytc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4ytc-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Disease	0.139	313	241	172	484	5	285	9.181E-05	127
LOKIASV2_1567_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLEX WITH 3-AMINO-6- [4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE	0.102	327	271	167	493	1	303	6.891E-05	127
LOKIASV2_1567_ESMFold_hypothetical_protein	7dv6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7dv6-assembly1.cif.gz_A Discovery of Functionally Selective Transforming Growth Factor beta Type II Receptor (TGF-beta RII) Inhibitors as Anti-Fibrosis Agents	0.139	302	256	180	481	5	302	1.060E-04	127
LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	0.104	307	225	180	486	9	260	3.503E-04	126
LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly2.cif.gz_B Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.107	308	239	180	487	11	279	2.070E-04	126
LOKIASV2_1567_ESMFold_hypothetical_protein	6unr-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6unr-assembly1.cif.gz_A Kinase domain of ALK2-K492A/K493A with AMPPNP	0.109	217	131	184	400	5	152	1.471E-03	126
LOKIASV2_1567_ESMFold_hypothetical_protein	3rvg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3rvg-assembly1.cif.gz_A Crystals structure of Jak2 with a 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitor	0.145	310	235	173	482	7	282	2.758E-04	126
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqf-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 12	0.138	313	238	168	480	17	293	1.412E-04	126
LOKIASV2_1567_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A TGF-beta Receptor type 1 in complex with SB431542	0.114	232	142	171	402	2	162	9.117E-04	126
LOKIASV2_1567_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB	LOKIASV2_1567_ESMFold_hypothetical_protein	7ozy-assembly2.cif.gz_BBB FGFR2 kinase domain (residues 461-763) in complex with 38.	0.099	312	240	171	482	11	277	1.554E-04	125
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqf-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqf-assembly2.cif.gz_C c-KIT kinase domain in complex with avapritinib derivative 12	0.134	313	241	168	480	17	295	1.973E-04	125
LOKIASV2_1567_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	0.129	259	148	143	401	6	176	2.389E-04	125
LOKIASV2_1567_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.125	318	224	174	491	12	268	2.506E-04	124
LOKIASV2_1567_ESMFold_hypothetical_protein	6i1s-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6i1s-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with FKBP12 and the inhibitor E6201	0.104	226	135	173	398	32	183	1.868E-03	124
LOKIASV2_1567_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	0.134	244	145	157	400	11	178	3.340E-04	124
LOKIASV2_1567_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6nvg-assembly1.cif.gz_A FGFR4 complex with N-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide	0.101	312	232	171	482	10	268	1.412E-04	123
LOKIASV2_1567_ESMFold_hypothetical_protein	2qoc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	0.107	307	229	180	486	9	265	2.629E-04	123
LOKIASV2_1567_ESMFold_hypothetical_protein	6vny-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6vny-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 10	0.123	313	244	173	485	7	285	4.667E-04	123
LOKIASV2_1567_ESMFold_hypothetical_protein	6drw-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6drw-assembly1.cif.gz_A JAK2 JH1 in complex with JNJ-7706621 (Crystal Form 2)	0.132	311	240	172	482	10	286	3.035E-04	123
LOKIASV2_1567_ESMFold_hypothetical_protein	6uns-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6uns-assembly2.cif.gz_B Kinase domain of ALK2-K492A/K493A with LDN-193189	0.103	228	137	171	398	1	154	1.274E-03	123
LOKIASV2_1567_ESMFold_hypothetical_protein	7v29-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7v29-assembly1.cif.gz_B Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	0.112	312	252	171	482	3	287	2.758E-04	123
LOKIASV2_1567_ESMFold_hypothetical_protein	4nw6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4nw6-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27	0.150	321	240	165	485	7	289	1.223E-04	123
LOKIASV2_1567_ESMFold_hypothetical_protein	6hdr-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6hdr-assembly1.cif.gz_A Human DYRK2 bound to Curcumin	0.144	223	131	176	398	94	247	9.564E-04	123
LOKIASV2_1567_ESMFold_hypothetical_protein	4gk4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4gk4-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 90	0.111	307	226	180	486	13	267	4.896E-04	122
LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_C Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.119	309	229	174	482	14	274	3.184E-04	122
LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly1.cif.gz_A Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.105	314	238	174	487	10	276	2.506E-04	122
LOKIASV2_1567_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7du9-assembly1.cif.gz_A Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	0.136	311	244	172	482	1	283	4.700E-05	122
LOKIASV2_1567_ESMFold_hypothetical_protein	4lrm-assembly5.cif.gz_E	LOKIASV2_1567_ESMFold_hypothetical_protein	4lrm-assembly5.cif.gz_E EGFR D770_N771insNPG in complex with PD168393	0.097	308	242	180	487	16	284	5.651E-04	122
LOKIASV2_1567_ESMFold_hypothetical_protein	6xx7-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6xx7-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal in complex with ANP	0.144	219	122	180	398	34	176	1.471E-03	122
LOKIASV2_1567_ESMFold_hypothetical_protein	6i5i-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6i5i-assembly1.cif.gz_A Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound 12h	0.123	326	279	166	491	7	325	4.481E-05	122
LOKIASV2_1567_ESMFold_hypothetical_protein	3ugc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3ugc-assembly1.cif.gz_A Structural basis of Jak2 inhibition by the type II inhibtor NVP-BBT594	0.126	310	233	173	482	5	272	1.346E-04	121
LOKIASV2_1567_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.102	312	238	180	491	2	267	1.881E-04	121
LOKIASV2_1567_ESMFold_hypothetical_protein	7c3g-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7c3g-assembly2.cif.gz_B Crystal structure of human ALK2 kinase domain with R206H mutation in complex with a bicyclic pyrazole inhibitor RK-73134	0.108	227	135	174	400	4	155	1.471E-03	121
LOKIASV2_1567_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	0.135	222	125	173	394	8	153	4.044E-04	121
LOKIASV2_1567_ESMFold_hypothetical_protein	1gol-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1gol-assembly1.cif.gz_A COORDINATES OF RAT MAP KINASE ERK2 WITH AN ARGININE MUTATION AT POSITION 52	0.107	233	140	171	403	18	175	8.286E-04	120
LOKIASV2_1567_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3tt0-assembly2.cif.gz_B Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	0.121	312	222	171	482	15	267	2.389E-04	119
LOKIASV2_1567_ESMFold_hypothetical_protein	2ivv-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	2ivv-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1	0.125	313	232	170	482	16	281	4.072E-05	119
LOKIASV2_1567_ESMFold_hypothetical_protein	5s7m-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5s7m-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000275d	0.113	226	134	169	394	1	152	1.158E-03	119
LOKIASV2_1567_ESMFold_hypothetical_protein	6vnx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6vnx-assembly1.cif.gz_A Crystal structure of TYK2 kinase with compound 19	0.125	317	246	171	487	5	286	7.530E-04	119
LOKIASV2_1567_ESMFold_hypothetical_protein	1pkg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1pkg-assembly1.cif.gz_A Structure of a c-Kit Kinase Product Complex	0.124	316	244	165	480	13	291	5.136E-04	119
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqc-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 9	0.149	313	236	168	480	17	294	2.278E-04	119
LOKIASV2_1567_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	0.131	239	137	163	401	25	183	7.899E-04	119
LOKIASV2_1567_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4h3q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.098	217	132	180	396	17	163	1.158E-03	119
LOKIASV2_1567_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	0.100	314	242	178	491	1	270	2.629E-04	118
LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.107	312	238	171	482	10	276	2.629E-04	118
LOKIASV2_1567_ESMFold_hypothetical_protein	1pkg-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	1pkg-assembly2.cif.gz_B Structure of a c-Kit Kinase Product Complex	0.130	317	229	166	482	15	278	3.675E-04	118
LOKIASV2_1567_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a	0.100	226	134	169	394	1	150	1.337E-03	118
LOKIASV2_1567_ESMFold_hypothetical_protein	6ylc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ylc-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	0.154	121	93	180	300	6	116	3.649E-03	118
LOKIASV2_1567_ESMFold_hypothetical_protein	7ju5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ju5-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with pralsetinib	0.145	315	233	168	482	11	283	4.072E-05	118
LOKIASV2_1567_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4v04-assembly2.cif.gz_B FGFR1 in complex with ponatinib.	0.100	312	239	171	482	16	282	1.793E-04	118
LOKIASV2_1567_ESMFold_hypothetical_protein	4w9x-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4w9x-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with baricitinib	0.117	219	136	176	394	4	158	1.052E-03	118
LOKIASV2_1567_ESMFold_hypothetical_protein	3vug-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vug-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1	0.121	225	146	172	396	1	167	9.564E-04	118
LOKIASV2_1567_ESMFold_hypothetical_protein	3lxl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3lxl-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	0.114	313	240	173	485	7	278	6.219E-04	117
LOKIASV2_1567_ESMFold_hypothetical_protein	6glb-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6glb-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 20 (FM484)	0.126	322	246	172	493	7	288	2.893E-04	117
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqd-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqd-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib derivative 10	0.140	313	240	168	480	17	296	1.973E-04	117
LOKIASV2_1567_ESMFold_hypothetical_protein	5nhf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5nhf-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	0.097	230	141	165	394	2	158	8.691E-04	117
LOKIASV2_1567_ESMFold_hypothetical_protein	6g97-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6g97-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	0.107	224	137	180	403	15	168	1.402E-03	117
LOKIASV2_1567_ESMFold_hypothetical_protein	6ges-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6ges-assembly2.cif.gz_B Crystal structure of ERK1 covalently bound to SM1-71	0.116	215	127	180	394	18	162	1.781E-03	117
LOKIASV2_1567_ESMFold_hypothetical_protein	6yg3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6yg3-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1	0.137	312	212	180	491	18	264	3.184E-04	116
LOKIASV2_1567_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4tyi-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4	0.104	318	241	165	482	5	274	5.387E-04	116
LOKIASV2_1567_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_A Structure of RET protein tyrosine kinase in complex with selpercatinib	0.127	318	248	165	482	1	285	6.569E-05	116
LOKIASV2_1567_ESMFold_hypothetical_protein	5lwm-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5lwm-assembly1.cif.gz_A Crystal structure of JAK3 in complex with Compound 4 (FM381)	0.126	321	247	173	493	7	290	3.035E-04	116
LOKIASV2_1567_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	0.109	311	269	162	472	20	322	1.481E-04	116
LOKIASV2_1567_ESMFold_hypothetical_protein	6ytg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ytg-assembly1.cif.gz_A CLK1 bound with beta-carboline KH-CARB13 (Cpd 3)	0.123	326	275	166	491	7	321	1.060E-04	116
LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly1.cif.gz_A Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	0.152	147	117	166	312	7	145	1.402E-03	116
LOKIASV2_1567_ESMFold_hypothetical_protein	3vui-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vui-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M2 in MAP kinase JNK1	0.121	225	146	172	396	1	167	1.003E-03	116
LOKIASV2_1567_ESMFold_hypothetical_protein	8ho6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8ho6-assembly1.cif.gz_A ScRIPK WT	0.128	298	225	185	482	22	280	6.843E-04	115
LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.117	321	246	171	491	11	290	3.700E-05	115
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqi-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib derivative 9	0.136	311	226	171	481	22	283	3.675E-04	115
LOKIASV2_1567_ESMFold_hypothetical_protein	6i5h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6i5h-assembly1.cif.gz_A Crystal structure of CLK1 in complex with furanopyrimidin VN412	0.129	326	270	166	491	7	317	8.752E-05	115
LOKIASV2_1567_ESMFold_hypothetical_protein	6fyo-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6fyo-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A	0.125	321	265	166	486	5	308	1.412E-04	115
LOKIASV2_1567_ESMFold_hypothetical_protein	6rq4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6rq4-assembly1.cif.gz_A Inhibitor of ERK2	0.107	234	141	170	403	2	160	1.003E-03	115
LOKIASV2_1567_ESMFold_hypothetical_protein	6qty-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qty-assembly1.cif.gz_A Non-phosphorylated human CLK1 in complex with an indole inhibitor to 1.65 Ang	0.124	321	268	166	486	4	310	1.481E-04	115
LOKIASV2_1567_ESMFold_hypothetical_protein	2fys-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2fys-assembly2.cif.gz_A Crystal structure of Erk2 complex with KIM peptide derived from MKP3	0.116	240	146	165	404	5	170	9.564E-04	115
LOKIASV2_1567_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_B-2	LOKIASV2_1567_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a	0.119	228	131	172	399	1	150	1.052E-03	114
LOKIASV2_1567_ESMFold_hypothetical_protein	3fxx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3fxx-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYE[pTyr]IW	0.109	307	230	180	486	16	274	5.928E-04	114
LOKIASV2_1567_ESMFold_hypothetical_protein	4ian-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4ian-assembly1.cif.gz_B Crystal Structure of apo Human PRPF4B kinase domain	0.142	227	134	168	394	5	161	1.543E-03	114
LOKIASV2_1567_ESMFold_hypothetical_protein	6ots-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ots-assembly1.cif.gz_A Rat ERK2 E320K	0.113	231	137	166	396	7	161	1.618E-03	114
LOKIASV2_1567_ESMFold_hypothetical_protein	6ise-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ise-assembly2.cif.gz_A Crystal structure of AMPPNP bound CK2 alpha from C. neoformans	0.116	263	155	139	401	4	179	7.899E-04	114
LOKIASV2_1567_ESMFold_hypothetical_protein	2vag-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2vag-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibitor	0.122	326	279	166	491	6	324	1.793E-04	114
LOKIASV2_1567_ESMFold_hypothetical_protein	3vuh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vuh-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M3 in MAP kinase JNK1	0.139	225	143	172	396	1	167	8.691E-04	114
LOKIASV2_1567_ESMFold_hypothetical_protein	4h1m-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4h1m-assembly1.cif.gz_A Crystal structure of PYK2 with the indole 10c	0.151	309	209	180	488	6	252	5.651E-04	113
LOKIASV2_1567_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4l01-assembly3.cif.gz_B Crystal structure of the V658F apo Jak1 pseudokinase domain	0.140	312	223	170	481	14	273	1.223E-04	113
LOKIASV2_1567_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4xuf-assembly2.cif.gz_B Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	0.117	309	237	167	475	3	271	4.896E-04	113
LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	7lgs-assembly3.cif.gz_C Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.129	314	231	174	487	11	276	4.896E-04	113
LOKIASV2_1567_ESMFold_hypothetical_protein	6gla-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6gla-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 11 (FM481)	0.124	321	244	173	493	8	286	5.928E-04	113
LOKIASV2_1567_ESMFold_hypothetical_protein	4xlv-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4xlv-assembly1.cif.gz_A Crystal structure of the activated insulin receptor tyrosine kinase dimer	0.108	330	256	156	485	6	293	4.044E-04	113
LOKIASV2_1567_ESMFold_hypothetical_protein	4ifc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4ifc-assembly1.cif.gz_A Crystal Structure of ADP-bound Human PRPF4B kinase domain	0.139	231	138	164	394	9	169	2.373E-03	113
LOKIASV2_1567_ESMFold_hypothetical_protein	6flv-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6flv-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.116	239	145	165	403	4	168	1.618E-03	113
LOKIASV2_1567_ESMFold_hypothetical_protein	2y9q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2y9q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.109	222	135	180	401	17	168	1.868E-03	113
LOKIASV2_1567_ESMFold_hypothetical_protein	3kul-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3kul-assembly2.cif.gz_B Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.082	317	247	168	484	2	271	8.286E-04	112
LOKIASV2_1567_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_B Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	0.163	223	121	174	396	5	150	2.056E-03	112
LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly2.cif.gz_D Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.105	320	234	174	493	14	276	2.171E-04	112
LOKIASV2_1567_ESMFold_hypothetical_protein	6gql-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6gql-assembly2.cif.gz_B Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 35)	0.137	313	241	168	480	6	285	2.278E-04	112
LOKIASV2_1567_ESMFold_hypothetical_protein	2x2k-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2x2k-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	0.120	309	233	174	482	21	286	8.343E-05	112
LOKIASV2_1567_ESMFold_hypothetical_protein	3h9r-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3h9r-assembly1.cif.gz_A Crystal structure of the kinase domain of type I activin receptor (ACVR1) in complex with FKBP12 and dorsomorphin	0.105	326	252	168	493	30	312	3.184E-04	112
LOKIASV2_1567_ESMFold_hypothetical_protein	5bue-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5bue-assembly1.cif.gz_A ERK2 complexed with N-benzylpyridone tetrahydroazaindazole	0.094	225	135	170	394	10	159	2.873E-03	112
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fv8-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E63	0.094	215	130	180	394	18	162	2.739E-03	112
LOKIASV2_1567_ESMFold_hypothetical_protein	2f49-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	2f49-assembly2.cif.gz_B Crystal structure of Fus3 in complex with a Ste5 peptide	0.124	225	131	170	394	8	157	1.781E-03	112
LOKIASV2_1567_ESMFold_hypothetical_protein	4xp3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4xp3-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	0.112	239	146	165	403	5	169	1.543E-03	112
LOKIASV2_1567_ESMFold_hypothetical_protein	5s7q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5s7q-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010944a	0.093	323	249	169	491	1	276	1.003E-03	111
LOKIASV2_1567_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4nus-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with LJH685	0.150	316	239	165	480	5	286	4.667E-04	111
LOKIASV2_1567_ESMFold_hypothetical_protein	5j1v-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	5j1v-assembly3.cif.gz_C Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW29 (compound 13)	0.165	159	125	166	316	7	165	1.052E-03	111
LOKIASV2_1567_ESMFold_hypothetical_protein	5j1w-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	5j1w-assembly3.cif.gz_C Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW31 (compound 14)	0.116	287	251	166	452	7	291	5.928E-04	111
LOKIASV2_1567_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS-9-003)	0.105	330	279	155	484	13	325	1.973E-04	111
LOKIASV2_1567_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ujs-assembly1.cif.gz_A Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and GluN2B in complex with ADP	0.110	316	233	173	488	5	267	5.136E-04	110
LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.125	320	226	171	490	11	269	1.630E-04	110
LOKIASV2_1567_ESMFold_hypothetical_protein	3gql-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	3gql-assembly3.cif.gz_C Crystal Structure of activated receptor tyrosine kinase in complex with substrates	0.106	312	229	171	482	11	267	3.855E-04	110
LOKIASV2_1567_ESMFold_hypothetical_protein	7aaz-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7aaz-assembly1.cif.gz_A Crystal structure of MerTK in complex with a type 1.5 aminopyridine inhibitor	0.106	303	242	180	482	14	285	4.449E-04	110
LOKIASV2_1567_ESMFold_hypothetical_protein	4r7i-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4r7i-assembly1.cif.gz_A Crystal structure of FMS kinase domain with a small molecular inhibitor, GLEEVEC	0.110	324	245	168	491	9	284	4.896E-04	110
LOKIASV2_1567_ESMFold_hypothetical_protein	8pq9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8pq9-assembly1.cif.gz_A c-KIT kinase domain in complex with avapritinib	0.136	313	240	168	480	17	295	1.166E-04	110
LOKIASV2_1567_ESMFold_hypothetical_protein	1gag-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1gag-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE INSULIN RECEPTOR KINASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR	0.104	325	255	160	484	1	286	6.523E-04	110
LOKIASV2_1567_ESMFold_hypothetical_protein	5bui-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5bui-assembly1.cif.gz_A ERK2 complexed with 2-pyridiyl tetrahydroazaindazole	0.109	238	144	170	407	10	172	1.543E-03	110
LOKIASV2_1567_ESMFold_hypothetical_protein	3v6r-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3v6r-assembly1.cif.gz_A Discovery of potent and selective covalent inhibitors of JNK	0.148	138	109	172	300	1	138	1.543E-03	110
LOKIASV2_1567_ESMFold_hypothetical_protein	7cil-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7cil-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 7	0.102	310	221	176	485	2	248	4.667E-04	109
LOKIASV2_1567_ESMFold_hypothetical_protein	4gk2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4gk2-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 66	0.109	315	223	168	482	5	255	1.274E-03	109
LOKIASV2_1567_ESMFold_hypothetical_protein	6yky-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6yky-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	0.141	128	105	180	307	3	125	4.635E-03	109
LOKIASV2_1567_ESMFold_hypothetical_protein	4rwj-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4rwj-assembly2.cif.gz_B Crystal Structure of FGFR1 (C488A, C584S) in complex with AZD4547 (N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE)	0.107	312	234	171	482	15	277	3.675E-04	109
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqe-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqe-assembly2.cif.gz_B c-KIT kinase domain in complex with avapritinib derivative 11	0.125	315	231	168	482	17	281	1.630E-04	109
LOKIASV2_1567_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.123	320	217	171	490	3	251	5.928E-04	109
LOKIASV2_1567_ESMFold_hypothetical_protein	6joi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6joi-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by co-crystallization	0.140	311	220	171	481	20	276	4.667E-04	109
LOKIASV2_1567_ESMFold_hypothetical_protein	8pqh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8pqh-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib	0.138	313	238	180	492	38	314	4.044E-04	109
LOKIASV2_1567_ESMFold_hypothetical_protein	2r9s-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	2r9s-assembly2.cif.gz_B c-Jun N-terminal Kinase 3 with 3,5-Disubstituted Quinoline inhibitor	0.147	223	124	171	393	15	160	1.337E-03	109
LOKIASV2_1567_ESMFold_hypothetical_protein	5bvf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5bvf-assembly1.cif.gz_A Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase	0.104	230	139	165	394	6	161	2.373E-03	109
LOKIASV2_1567_ESMFold_hypothetical_protein	5nhp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5nhp-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	0.096	230	141	165	394	3	159	2.489E-03	109
LOKIASV2_1567_ESMFold_hypothetical_protein	4zzn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4zzn-assembly1.cif.gz_A Human ERK2 in complex with an inhibitor	0.099	234	142	170	403	10	168	1.781E-03	109
LOKIASV2_1567_ESMFold_hypothetical_protein	6eq9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6eq9-assembly1.cif.gz_A Crystal structure of JNK3 in complex with AMP-PCP	0.158	130	103	171	300	15	137	2.373E-03	109
LOKIASV2_1567_ESMFold_hypothetical_protein	4l7f-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4l7f-assembly1.cif.gz_A Co-crystal Structure of JNK1 and AX13587	0.157	128	107	180	307	22	149	1.471E-03	109
LOKIASV2_1567_ESMFold_hypothetical_protein	7aw4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7aw4-assembly1.cif.gz_A MerTK kinase domain with type 3 inhibitor from a DNA-encoded library	0.105	305	224	180	484	12	262	7.530E-04	108
LOKIASV2_1567_ESMFold_hypothetical_protein	7cja-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7cja-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 28	0.115	310	216	176	485	2	246	3.035E-04	108
LOKIASV2_1567_ESMFold_hypothetical_protein	4p4c-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4p4c-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	0.107	307	220	180	486	9	255	1.337E-03	108
LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	0.110	311	231	176	486	2	262	2.262E-03	108
LOKIASV2_1567_ESMFold_hypothetical_protein	8c09-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8c09-assembly1.cif.gz_A Crystal structure of JAK2 JH2-I559F	0.117	310	235	172	481	5	271	5.387E-04	108
LOKIASV2_1567_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5u6c-assembly1.cif.gz_A Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor	0.115	315	228	170	484	10	268	5.136E-04	108
LOKIASV2_1567_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8b8n-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Cdk2 inhibitor IV	0.125	311	231	171	481	6	270	4.667E-04	108
LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4j95-assembly6.cif.gz_C Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.108	320	241	171	490	9	279	2.389E-04	108
LOKIASV2_1567_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3we4-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole	0.208	132	100	169	300	1	127	3.014E-03	108
LOKIASV2_1567_ESMFold_hypothetical_protein	6r6e-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6r6e-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1-methyl-1H-indol-3-yl)pyrimidin-4-amine	0.126	324	277	167	490	1	318	4.044E-04	108
LOKIASV2_1567_ESMFold_hypothetical_protein	7ore-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ore-assembly1.cif.gz_A Crystal structure of JNK3 in complex with light-activated covalent inhibitor MR-II-249 with both non-covalent and covalent binding modes (compound 4)	0.159	130	103	171	300	17	139	2.262E-03	108
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4g-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4c4g-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.118	296	216	176	471	2	247	3.035E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	5am6-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5am6-assembly2.cif.gz_B Native FGFR1 with an inhibitor	0.093	312	236	171	482	16	276	9.117E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	6wxj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6wxj-assembly1.cif.gz_A CSF1R signaling is a regulator of pathogenesis in progressive MS	0.113	326	235	168	493	17	282	4.667E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6p69-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.	0.106	312	240	171	482	13	282	5.387E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	6gqk-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6gqk-assembly2.cif.gz_B Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)	0.148	313	239	168	480	11	292	3.675E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	6xvb-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6xvb-assembly1.cif.gz_A Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788	0.133	317	244	168	484	14	296	8.286E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_D The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.096	312	258	171	482	10	295	1.346E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	4l44-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4l44-assembly1.cif.gz_A Crystal structures of human p70S6K1-T389A (form II)	0.171	230	131	166	395	1	159	2.611E-03	107
LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly3.cif.gz_C Crystal structure of CLK1 in complex with CX-4945	0.122	326	277	166	491	3	319	4.242E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	0.146	234	138	165	398	1	163	4.212E-03	107
LOKIASV2_1567_ESMFold_hypothetical_protein	3i5z-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3i5z-assembly1.cif.gz_A Crystal structure of ERK2 bound to (S)-N-(2-hydroxy-1-phenylethyl)-4-(5-methyl-2-(phenylamino)pyrimidin-4-yl)-1H-pyrrole-2-carboxamide	0.094	215	130	180	394	18	162	3.014E-03	107
LOKIASV2_1567_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2f9g-assembly1.cif.gz_A Crystal structure of Fus3 phosphorylated on Tyr182	0.126	317	228	170	486	8	269	2.893E-04	107
LOKIASV2_1567_ESMFold_hypothetical_protein	3w55-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3w55-assembly1.cif.gz_A The structure of ERK2 in complex with FR148083	0.094	227	137	170	396	10	161	2.373E-03	107
LOKIASV2_1567_ESMFold_hypothetical_protein	6fr1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6fr1-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.105	239	147	165	403	4	168	1.781E-03	107
LOKIASV2_1567_ESMFold_hypothetical_protein	4o6l-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4o6l-assembly2.cif.gz_B Crystal Structure of TTK kinase domain with an inhibitor: 401498 (N-[(1R)-1-(2-chlorophenyl)propyl]-3-{4-[(1-methylpiperidin-4-yl)oxy]phenyl}-1H-indazole-5-carboxamide)	0.113	318	209	176	493	2	238	4.896E-04	106
LOKIASV2_1567_ESMFold_hypothetical_protein	6xjk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6xjk-assembly1.cif.gz_A JAK2 JH2 in complex with JAK067	0.122	308	226	174	481	6	263	5.651E-04	106
LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly6.cif.gz_D Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.113	312	235	171	482	13	278	2.171E-04	106
LOKIASV2_1567_ESMFold_hypothetical_protein	4rwk-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4rwk-assembly2.cif.gz_B Crystal structure of V561M FGFR1 gatekeeper mutation (C488A, C584S, V561M) in complex with N-{3-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-5-YL}-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE (AZD4547)	0.096	312	237	171	482	15	277	6.843E-04	106
LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly2.cif.gz_C The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.101	312	244	171	482	10	281	1.710E-04	106
LOKIASV2_1567_ESMFold_hypothetical_protein	6xva-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6xva-assembly1.cif.gz_A Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor bearing an acrylamide	0.139	313	240	168	480	14	293	2.506E-04	106
LOKIASV2_1567_ESMFold_hypothetical_protein	4ijp-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4ijp-assembly2.cif.gz_B Crystal Structure of Human PRPF4B kinase domain in complex with 4-{5-[(2-Chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine	0.147	231	136	164	394	9	169	5.651E-04	106
LOKIASV2_1567_ESMFold_hypothetical_protein	3qyz-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3qyz-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	0.096	239	149	165	403	2	167	1.868E-03	106
LOKIASV2_1567_ESMFold_hypothetical_protein	6g92-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6g92-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	0.113	238	145	166	403	8	171	2.156E-03	106
LOKIASV2_1567_ESMFold_hypothetical_protein	3vul-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vul-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	0.113	317	214	172	488	1	242	2.389E-04	106
LOKIASV2_1567_ESMFold_hypothetical_protein	4xj0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4xj0-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor 14K	0.100	240	146	170	409	9	171	1.618E-03	106
LOKIASV2_1567_ESMFold_hypothetical_protein	7w5c-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7w5c-assembly1.cif.gz_A Crystal structure of Mitogen Activated Protein Kinase 4 (MPK4) from Arabidopsis thaliana	0.119	226	135	171	396	21	174	3.014E-03	106
LOKIASV2_1567_ESMFold_hypothetical_protein	5a4e-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	5a4e-assembly3.cif.gz_C DYRK1A in complex with methoxy benzothiazole fragment	0.139	230	141	168	397	13	177	2.056E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4j99-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.	0.109	312	236	171	482	12	277	1.630E-04	105
LOKIASV2_1567_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	0.132	315	241	169	483	1	279	1.337E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7ju6-assembly1.cif.gz_B Structure of RET protein tyrosine kinase in complex with selpercatinib	0.132	315	240	168	482	11	288	3.035E-04	105
LOKIASV2_1567_ESMFold_hypothetical_protein	4j98-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4j98-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.	0.121	321	251	171	491	17	303	1.710E-04	105
LOKIASV2_1567_ESMFold_hypothetical_protein	4hys-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4hys-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan	0.138	128	109	180	307	19	146	2.373E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	7a5n-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7a5n-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 34	0.144	228	139	170	397	6	168	2.262E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	5bve-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5bve-assembly1.cif.gz_A Tetrahydropyrrolo-diazepenones as inhibitors of ERK2 kinase	0.098	215	130	180	394	17	161	4.635E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	3i60-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3i60-assembly1.cif.gz_A Crystal structure of ERK2 bound to (S)-4-(2-(2-chlorophenylamino)-5-methylpyrimidin-4-yl)-N-(2-hydroxy-1-phenylethyl)-1H-pyrrole-2-carboxamide	0.090	224	135	171	394	14	162	3.479E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	4myg-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4myg-assembly2.cif.gz_B MAPK13, active form	0.100	219	131	176	394	10	156	5.612E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	4xrl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4xrl-assembly1.cif.gz_A Crystal structure at room temperature of Erk2 in complex with an inhibitor	0.102	234	142	170	403	10	168	3.828E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	8ao2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8ao2-assembly1.cif.gz_A Specific covalent inhibitor (3) of ERK2	0.114	238	144	166	403	3	166	1.960E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	6g9h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6g9h-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	0.100	239	149	165	403	2	168	1.960E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	4awi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4awi-assembly1.cif.gz_A Human Jnk1alpha kinase with 4-phenyl-7-azaindole IKK2 inhibitor.	0.160	121	99	180	300	19	137	3.649E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	7yl1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7yl1-assembly1.cif.gz_A Crystal structure of JNK3 in complex with a fragment molecule	0.149	138	109	172	300	1	138	2.373E-03	105
LOKIASV2_1567_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3gql-assembly4.cif.gz_B Crystal Structure of activated receptor tyrosine kinase in complex with substrates	0.117	312	228	171	482	11	269	2.278E-04	104
LOKIASV2_1567_ESMFold_hypothetical_protein	6yi8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6yi8-assembly1.cif.gz_A HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	0.107	315	236	171	485	10	274	1.166E-04	104
LOKIASV2_1567_ESMFold_hypothetical_protein	5grn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5grn-assembly1.cif.gz_A Crystal structure of PDGFRA in Complex with WQ-C-159	0.144	313	237	171	483	5	282	1.158E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6v6q-assembly1.cif.gz_A Crystal Structure of Monophosphorylated FGF Receptor 2 isoform IIIb with PTR657	0.115	320	240	174	493	15	286	3.340E-04	104
LOKIASV2_1567_ESMFold_hypothetical_protein	7c3n-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7c3n-assembly1.cif.gz_A Crystal structure of JAK3 in complex with Delgocitinib	0.117	320	249	172	491	6	288	1.402E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	8p04-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8p04-assembly1.cif.gz_A Crystal structure of human CLK1 in complex with Leucettinib-92	0.132	326	266	166	491	6	313	5.136E-04	104
LOKIASV2_1567_ESMFold_hypothetical_protein	1z57-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1z57-assembly1.cif.gz_A Crystal structure of human CLK1 in complex with 10Z-Hymenialdisine	0.120	321	266	166	486	7	309	4.667E-04	104
LOKIASV2_1567_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A Crystal structure of non-phosphorylated Fus3	0.111	327	280	171	486	9	335	3.503E-04	104
LOKIASV2_1567_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.093	238	147	170	407	10	172	1.274E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	6pk6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6pk6-assembly1.cif.gz_A Human PRPF4B bound to benzothiophene inhibitor 329	0.148	231	136	164	394	9	169	1.471E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	6z4z-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6z4z-assembly2.cif.gz_B Crystal structure of CLK1 in complex with macrocycle ODS2004070	0.125	326	281	166	491	7	328	5.387E-04	104
LOKIASV2_1567_ESMFold_hypothetical_protein	6fj0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6fj0-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.113	224	136	180	403	15	168	3.316E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	4n4s-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4n4s-assembly1.cif.gz_A A Double Mutant Rat Erk2 in Complex With a Pyrazolo[3,4-d]pyrimidine Inhibitor	0.097	230	141	165	394	4	160	3.014E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	8bzp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8bzp-assembly1.cif.gz_A JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	0.153	128	106	180	307	19	144	1.960E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	4kke-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4kke-assembly1.cif.gz_A The crystal structure of AMP-bound JNK3	0.147	138	109	172	300	1	138	1.960E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	5lw1-assembly3.cif.gz_H	LOKIASV2_1567_ESMFold_hypothetical_protein	5lw1-assembly3.cif.gz_H Crystal structure of DARPin-DARPin rigid fusion, variant DD_232_11_D12 in complex JNK1a1 and JIP1 peptide	0.139	214	124	180	393	19	163	3.828E-03	104
LOKIASV2_1567_ESMFold_hypothetical_protein	6x8g-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6x8g-assembly1.cif.gz_A Crystal structure of TYK2 with Compound 22	0.119	316	240	172	487	6	278	2.611E-03	103
LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6agx-assembly1.cif.gz_A The cocrystal structure of FGFR2 bound with compound 14 harboring 5H-pyrrolo[2,3-b]pyrazine scaffold	0.103	312	244	171	482	10	282	3.855E-04	103
LOKIASV2_1567_ESMFold_hypothetical_protein	5amn-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	5amn-assembly1.cif.gz_A-2 The Discovery of 2-Substituted Phenol Quinazolines as Potent and Selective RET Kinase Inhibitors	0.127	312	241	171	482	12	288	4.242E-04	103
LOKIASV2_1567_ESMFold_hypothetical_protein	5ew8-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5ew8-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 1 IN COMPLEX WITH JNJ-4275693	0.097	309	240	174	482	17	283	4.896E-04	103
LOKIASV2_1567_ESMFold_hypothetical_protein	5flf-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	5flf-assembly4.cif.gz_D DISEASE LINKED MUTATION IN FGFR	0.111	319	245	171	489	9	285	1.412E-04	103
LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly2.cif.gz_B Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	0.123	325	276	166	490	7	322	5.928E-04	103
LOKIASV2_1567_ESMFold_hypothetical_protein	6q2a-assembly13.cif.gz_M	LOKIASV2_1567_ESMFold_hypothetical_protein	6q2a-assembly13.cif.gz_M Trypanosoma brucei CLK1 kinase domain in complex with a covalent aminobenzimidazole inhibitor AB1	0.135	126	102	174	299	2	120	8.228E-03	103
LOKIASV2_1567_ESMFold_hypothetical_protein	3o71-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3o71-assembly1.cif.gz_A Crystal structure of ERK2/DCC peptide complex	0.084	228	141	169	396	7	161	2.262E-03	103
LOKIASV2_1567_ESMFold_hypothetical_protein	6ot6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ot6-assembly1.cif.gz_A Rat ERK2 D319N	0.116	239	145	165	403	4	168	4.862E-03	103
LOKIASV2_1567_ESMFold_hypothetical_protein	5jrs-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5jrs-assembly2.cif.gz_A CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	0.104	309	224	174	482	7	257	1.158E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	6bss-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6bss-assembly1.cif.gz_A JAK2 JH2 in complex with NU6102	0.121	310	230	172	481	6	268	1.052E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	7t1t-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7t1t-assembly1.cif.gz_A JAK2 JH2 IN COMPLEX WITH JAK292	0.113	310	236	172	481	7	273	1.052E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	6v9c-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6v9c-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with covalent inhibitor	0.117	312	234	171	482	10	275	3.675E-04	102
LOKIASV2_1567_ESMFold_hypothetical_protein	3krl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3krl-assembly1.cif.gz_A cFMS Tyrosine kinase in complex with 5-Cyano-furan-2-carboxylic acid [4-(4-methyl-piperazin-1-yl)-2-piperidin-1-yl-phenyl]-amide	0.117	320	234	168	487	15	280	1.215E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	0.101	313	245	180	492	2	274	1.698E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	0.135	320	234	166	485	1	271	1.104E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.115	336	266	157	492	2	303	4.667E-04	102
LOKIASV2_1567_ESMFold_hypothetical_protein	1pme-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1pme-assembly1.cif.gz_A STRUCTURE OF PENTA MUTANT HUMAN ERK2 MAP KINASE COMPLEXED WITH A SPECIFIC INHIBITOR OF HUMAN P38 MAP KINASE	0.107	234	138	170	403	5	160	2.611E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	4x21-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4x21-assembly1.cif.gz_A The MAP kinase JNK3 as target for halogen bonding	0.153	121	100	180	300	19	137	3.014E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	8aof-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8aof-assembly1.cif.gz_A Specific covalent inhibitor(16) of ERK2	0.113	234	136	170	403	10	163	1.698E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	3nr9-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	3nr9-assembly1.cif.gz_A-2 Structure of human CDC2-like kinase 2 (CLK2)	0.112	327	280	165	491	17	332	4.667E-04	102
LOKIASV2_1567_ESMFold_hypothetical_protein	4kkg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4kkg-assembly1.cif.gz_A Crystal structure of apo and AMP-bound JNK3	0.148	139	110	172	301	1	139	3.316E-03	102
LOKIASV2_1567_ESMFold_hypothetical_protein	4cv9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4cv9-assembly1.cif.gz_A MPS1 kinase with 3-aminopyridin-2-one inhibitors	0.116	301	222	176	476	2	253	8.691E-04	101
LOKIASV2_1567_ESMFold_hypothetical_protein	5ap4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ap4-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.111	295	222	177	471	3	253	8.691E-04	101
LOKIASV2_1567_ESMFold_hypothetical_protein	4nks-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4nks-assembly2.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 3	0.097	312	230	171	482	13	268	1.402E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	0.123	310	231	172	481	7	270	1.402E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	3ky2-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3ky2-assembly2.cif.gz_B Crystal structure of Fibroblast Growth Factor Receptor 1 kinase domain	0.109	312	233	171	482	14	275	2.611E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.104	321	245	171	491	10	283	7.178E-04	101
LOKIASV2_1567_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3ri1-assembly1.cif.gz_A Crystal structure of the catalytic domain of FGFR2 kinase in complex with ARQ 069	0.117	323	249	171	493	3	285	7.899E-04	101
LOKIASV2_1567_ESMFold_hypothetical_protein	7v29-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7v29-assembly2.cif.gz_A Crystal structure of FGFR4 with a dual-warhead covalent inhhibitor	0.118	312	253	171	482	3	290	3.184E-04	101
LOKIASV2_1567_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_A Human tnik in complex with compound 9	0.117	313	246	174	486	13	292	1.274E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	6ig8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ig8-assembly1.cif.gz_A Crystal structure of CSF-1R kinase domain with a small molecular inhibitor, JTE-952	0.107	320	251	168	487	19	300	1.274E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	5ywm-assembly1.cif.gz_X	LOKIASV2_1567_ESMFold_hypothetical_protein	5ywm-assembly1.cif.gz_X Crystal structure of CK2a2 form-1	0.140	223	122	180	402	34	176	4.862E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	4ijp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4ijp-assembly1.cif.gz_A Crystal Structure of Human PRPF4B kinase domain in complex with 4-{5-[(2-Chloro-pyridin-4-ylmethyl)-carbamoyl]-thiophen-2-yl}-benzo[b]thiophene-2-carboxylic acid amine	0.132	230	138	165	394	8	167	2.373E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	6fi6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6fi6-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.108	239	146	165	403	4	168	3.479E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	4xp2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4xp2-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	0.103	224	137	180	403	16	169	5.612E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	6ytd-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ytd-assembly1.cif.gz_A CLK1 V324A mutant bound with benzothiazole Tg003 (Cpd 2)	0.125	326	281	166	491	7	328	5.136E-04	101
LOKIASV2_1567_ESMFold_hypothetical_protein	4iz7-assembly1.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4iz7-assembly1.cif.gz_C Structure of Non-Phosphorylated ERK2 bound to the PEA-15 Death Effector Domain	0.097	237	147	165	401	3	166	3.161E-03	101
LOKIASV2_1567_ESMFold_hypothetical_protein	6b4w-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6b4w-assembly1.cif.gz_A TTK in Complex with Inhibitor	0.118	318	211	176	493	2	241	7.178E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6tu9-assembly2.cif.gz_B The ROR1 Pseudokinase Domain Bound To Ponatinib	0.096	315	232	167	481	1	258	2.373E-03	100
LOKIASV2_1567_ESMFold_hypothetical_protein	7chn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7chn-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 9	0.132	301	226	176	476	2	262	8.691E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	0.121	210	127	185	394	17	161	5.887E-03	100
LOKIASV2_1567_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5ugl-assembly2.cif.gz_B Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.114	321	229	171	491	11	270	6.219E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	5lpv-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5lpv-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with AMPPNP and Mn from Arabidopsis thaliana	0.114	305	231	185	489	22	283	2.739E-03	100
LOKIASV2_1567_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ugl-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation	0.117	318	239	174	491	13	284	4.896E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7kia-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.111	321	244	171	491	11	286	5.136E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	7mfc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7mfc-assembly1.cif.gz_A Crystal structure of CSF1R in complex with vimseltinib	0.112	317	246	168	484	9	286	1.274E-03	100
LOKIASV2_1567_ESMFold_hypothetical_protein	6xv9-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6xv9-assembly2.cif.gz_B Crystal structure of the kinase domain of human c-KIT in complex with a type-II inhibitor	0.126	313	245	168	480	11	291	3.675E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ui0-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.115	322	250	171	492	17	299	3.184E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6t2w-assembly1.cif.gz_A Crystal structure of the CSF1R kinase domain with a dihydropurinone inhibitor (compound 4)	0.108	324	246	168	491	27	303	7.178E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly2.cif.gz_B Crystal structure of CLK1 in complex with CX-4945	0.131	327	278	165	491	3	323	5.136E-04	100
LOKIASV2_1567_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2ghl-assembly1.cif.gz_A Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor PG-874743	0.122	213	123	180	392	20	160	4.212E-03	100
LOKIASV2_1567_ESMFold_hypothetical_protein	6fyk-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6fyk-assembly2.cif.gz_B X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A	0.153	159	126	165	314	17	175	3.479E-03	100
LOKIASV2_1567_ESMFold_hypothetical_protein	7orf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7orf-assembly1.cif.gz_A Crystal structure of JNK3 in complex with FMU-001-367 (compound 1)	0.129	138	111	172	300	1	138	2.056E-03	100
LOKIASV2_1567_ESMFold_hypothetical_protein	5c03-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5c03-assembly1.cif.gz_A Crystal Structure of kinase	0.127	302	217	180	481	11	260	2.156E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7vjl-assembly2.cif.gz_B The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(2,2,2-trifluoroacetyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide	0.098	309	222	174	482	14	260	4.044E-04	99
LOKIASV2_1567_ESMFold_hypothetical_protein	6yi8-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6yi8-assembly2.cif.gz_B HUMAN FGFR4 KINASE DOMAIN (447-753) IN COMPLEX WITH ROBLITINIB	0.118	312	223	171	482	12	265	2.389E-04	99
LOKIASV2_1567_ESMFold_hypothetical_protein	4twn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4twn-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with Birb796	0.107	307	225	180	486	14	266	2.262E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	4hw7-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4hw7-assembly1.cif.gz_A Crystal structure of FMS kinase domain with a small molecular inhibitor, PLX647-OME	0.113	317	246	168	484	10	287	1.337E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	1t46-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1t46-assembly1.cif.gz_A STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE	0.130	317	240	168	484	18	294	1.003E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	3krj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3krj-assembly1.cif.gz_A cFMS tyrosine kinase in complex with 4-Cyano-1H-imidazole-2-carboxylic acid (2-cyclohex-1-enyl-4-piperidin-4-yl-phenyl)-amide	0.114	309	238	168	476	32	301	9.564E-04	99
LOKIASV2_1567_ESMFold_hypothetical_protein	6opi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6opi-assembly1.cif.gz_A phosphorylated ERK2 with SCH-CPD336	0.103	325	286	165	489	5	324	5.651E-04	99
LOKIASV2_1567_ESMFold_hypothetical_protein	4o6e-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4o6e-assembly1.cif.gz_A Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine Inhibitors of Erk2	0.101	327	289	166	492	3	324	4.044E-04	99
LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6q8p-assembly3.cif.gz_C Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	0.127	321	265	166	486	6	309	1.158E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qp2-assembly1.cif.gz_A Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine	0.096	232	140	170	401	9	164	5.350E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	5nho-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5nho-assembly1.cif.gz_A Human Erk2 with an Erk1/2 inhibitor	0.092	230	141	165	394	4	159	3.479E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	2eu9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2eu9-assembly1.cif.gz_A Crystal Structure of CLK3	0.140	157	126	165	312	11	167	4.862E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	5lcj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5lcj-assembly1.cif.gz_A In-Gel Activity-Based Protein Profiling of a Clickable Covalent Erk 1/2 Inhibitor	0.113	238	145	166	403	5	168	6.176E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	6z55-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6z55-assembly2.cif.gz_B Crystal structure of CLK3 in complex with macrocycle ODS2004070	0.137	159	129	165	314	19	177	2.873E-03	99
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4j-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4c4j-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.101	310	220	176	485	1	246	1.337E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8c08-assembly1.cif.gz_A Crystal structure of JAK2 JH2-K539L	0.130	312	227	170	481	4	265	1.337E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	7k0v-assembly1.cif.gz_D Crystal structure of bRaf in complex with inhibitor GNE-0749	0.098	312	240	170	481	4	270	1.698E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	7olx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7olx-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole group	0.110	309	223	174	482	20	271	1.215E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	3dpk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3dpk-assembly1.cif.gz_A cFMS tyrosine kinase in complex with a pyridopyrimidinone inhibitor	0.123	285	210	168	452	20	260	2.611E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	4qqj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qqj-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain Harboring the V550L Gate-Keeper Mutation	0.128	312	239	171	482	3	277	7.899E-04	98
LOKIASV2_1567_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5ugx-assembly1.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation	0.124	321	237	171	491	10	281	5.651E-04	98
LOKIASV2_1567_ESMFold_hypothetical_protein	3qqu-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3qqu-assembly2.cif.gz_B Cocrystal structure of unphosphorylated igf with pyrimidine 8	0.114	319	200	166	484	3	229	2.156E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	3wf8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3wf8-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a quinoline derivative 2-oxo-2-[(4-sulfamoylphenyl)amino]ethyl 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinoline-11-carboxylate	0.152	315	239	169	483	1	283	1.698E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	6yti-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6yti-assembly1.cif.gz_A CLK1 bound with ETH1610 (Cpd 17)	0.125	326	277	166	491	3	320	7.899E-04	98
LOKIASV2_1567_ESMFold_hypothetical_protein	3tei-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3tei-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.090	224	135	171	394	12	160	4.212E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	4y46-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4y46-assembly1.cif.gz_A Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) inhibitors	0.148	138	109	172	300	1	138	5.100E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	4yno-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4yno-assembly1.cif.gz_A Crystal structure of MAPK13 at INACTIVE FORM	0.089	228	149	172	399	5	169	3.014E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly1.cif.gz_A Crystal structure of JNK1 bound to a MKK7 docking motif	0.105	323	275	180	487	19	341	6.219E-04	98
LOKIASV2_1567_ESMFold_hypothetical_protein	2gph-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2gph-assembly1.cif.gz_A Docking motif interactions in the MAP kinase ERK2	0.105	232	141	165	396	3	160	4.419E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	4s2z-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4s2z-assembly1.cif.gz_A ERK2 Intrinsically active mutant R65S	0.101	238	147	166	403	4	168	4.212E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	3v6r-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3v6r-assembly2.cif.gz_B Discovery of potent and selective covalent inhibitors of JNK	0.148	138	109	172	300	1	138	4.016E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	7e75-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7e75-assembly1.cif.gz_A Crystal structure of human ERK2 mutant (G37C)	0.105	230	139	165	394	5	160	4.212E-03	98
LOKIASV2_1567_ESMFold_hypothetical_protein	6tn9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6tn9-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 16	0.120	296	220	176	471	4	254	8.691E-04	97
LOKIASV2_1567_ESMFold_hypothetical_protein	7cht-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7cht-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 30	0.117	296	224	176	471	2	256	7.530E-04	97
LOKIASV2_1567_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	0.112	321	239	171	491	10	279	4.242E-04	97
LOKIASV2_1567_ESMFold_hypothetical_protein	5uhn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5uhn-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	0.096	318	243	174	491	12	281	6.843E-04	97
LOKIASV2_1567_ESMFold_hypothetical_protein	7ozd-assembly2.cif.gz_BBB	LOKIASV2_1567_ESMFold_hypothetical_protein	7ozd-assembly2.cif.gz_BBB FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 34.	0.103	312	239	171	482	14	280	4.667E-04	97
LOKIASV2_1567_ESMFold_hypothetical_protein	5ui0-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5ui0-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation	0.106	323	257	171	493	16	304	4.667E-04	97
LOKIASV2_1567_ESMFold_hypothetical_protein	3bea-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3bea-assembly1.cif.gz_A cFMS tyrosine kinase (tie2 KID) in complex with a pyrimidinopyridone inhibitor	0.123	326	243	168	493	29	306	1.158E-03	97
LOKIASV2_1567_ESMFold_hypothetical_protein	4eyj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4eyj-assembly1.cif.gz_A MAPK13 Complex with inhibitor	0.083	222	149	172	393	5	168	4.212E-03	97
LOKIASV2_1567_ESMFold_hypothetical_protein	1pmn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1pmn-assembly1.cif.gz_A Crystal structure of JNK3 in complex with an imidazole-pyrimidine inhibitor	0.164	146	114	172	308	1	146	2.489E-03	97
LOKIASV2_1567_ESMFold_hypothetical_protein	6ge0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ge0-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	0.099	234	142	170	403	10	168	7.477E-03	97
LOKIASV2_1567_ESMFold_hypothetical_protein	4d2s-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4d2s-assembly1.cif.gz_A Human TTK in complex with a Dyrk1B inhibitor	0.113	310	204	176	485	4	234	1.003E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4e-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4c4e-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.117	296	222	176	471	1	252	1.337E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	6occ-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6occ-assembly1.cif.gz_A JAK2 JH2 in complex with JAK190	0.113	314	230	172	485	6	265	1.104E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	4rix-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4rix-assembly1.cif.gz_A Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-Q790R mutation	0.102	308	227	180	487	11	264	7.178E-04	96
LOKIASV2_1567_ESMFold_hypothetical_protein	8c0a-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8c0a-assembly2.cif.gz_B Crystal structure of JAK2 JH2-R683S	0.127	310	230	172	481	7	270	1.781E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	6qhr-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qhr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1m	0.142	310	225	180	489	20	282	9.117E-04	96
LOKIASV2_1567_ESMFold_hypothetical_protein	3hng-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3hng-assembly1.cif.gz_A Crystal structure of VEGFR1 in complex with N-(4-Chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzamide	0.127	311	234	171	481	19	287	2.489E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	6xvb-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6xvb-assembly2.cif.gz_B Crystal structure of the kinase domain of human c-KIT with a cyclic imidate inhibitor covalently bound to Cys788	0.127	317	245	168	484	6	287	5.387E-04	96
LOKIASV2_1567_ESMFold_hypothetical_protein	7ozb-assembly2.cif.gz_BBB	LOKIASV2_1567_ESMFold_hypothetical_protein	7ozb-assembly2.cif.gz_BBB FGFR1 kinase domain (residues 458-765) with mutations C488A, C584S in complex with 38.	0.106	312	242	171	482	14	285	4.449E-04	96
LOKIASV2_1567_ESMFold_hypothetical_protein	6pnx-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6pnx-assembly1.cif.gz_B Crystal Structure of an Asymmetric Dimer of FGF Receptor 3 Kinases Trapped in A-loop Tyrosine Transphosphorylation Reaction	0.101	312	249	171	482	13	290	5.651E-04	96
LOKIASV2_1567_ESMFold_hypothetical_protein	7ybp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ybp-assembly1.cif.gz_A Crystal structure of FGFR4(V550L) kinase domain with 10z	0.112	312	258	171	482	4	295	3.675E-04	96
LOKIASV2_1567_ESMFold_hypothetical_protein	4xoy-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4xoy-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an inhibitor	0.099	239	144	165	403	3	163	4.635E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	3ttj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3ttj-assembly1.cif.gz_A Crystal Structure of JNK3 complexed with CC-359, a JNK inhibitor for the prevention of ischemia-reperfusion injury	0.152	134	107	174	300	2	135	5.887E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	7ugb-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ugb-assembly1.cif.gz_A Crystal structure of rat ERK2 complexed with docking peptide from ISG20	0.095	328	296	165	492	3	330	8.691E-04	96
LOKIASV2_1567_ESMFold_hypothetical_protein	4qta-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qta-assembly1.cif.gz_A Structure of human ERK2 in complex with SCH772984 revealing a novel inhibitor-induced binding pocket	0.100	232	141	165	396	5	162	7.477E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	6fjb-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6fjb-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.099	234	142	170	403	9	167	6.478E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	7nr3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7nr3-assembly1.cif.gz_A Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2	0.103	330	292	166	492	5	334	1.003E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	6ytw-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6ytw-assembly2.cif.gz_B CLK3 bound with benzothiazole Tg003 (Cpd 2)	0.126	253	188	165	417	13	228	3.649E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	3e7o-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3e7o-assembly2.cif.gz_A Crystal Structure of JNK2	0.119	223	130	171	393	14	162	3.649E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	4iz7-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4iz7-assembly2.cif.gz_A Structure of Non-Phosphorylated ERK2 bound to the PEA-15 Death Effector Domain	0.104	232	141	165	396	4	161	9.963E-03	96
LOKIASV2_1567_ESMFold_hypothetical_protein	3vuk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vuk-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M5 in MAP kinase JNK1	0.115	315	258	172	486	1	293	5.651E-04	96
LOKIASV2_1567_ESMFold_hypothetical_protein	4zeg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4zeg-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor	0.107	296	226	176	471	1	254	2.056E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	5ur1-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5ur1-assembly2.cif.gz_B FGFR1 kinase domain complex with SN37333 in reversible binding mode	0.111	312	222	171	482	10	260	1.104E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A Human Nek2 kinase ATPgammaS-bound	0.102	214	131	180	393	6	152	5.612E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	7lvh-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7lvh-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	0.110	304	236	176	479	3	268	1.868E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	4qqt-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qqt-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Tyrosine Kinase Domain	0.109	307	238	176	482	13	280	5.928E-04	95
LOKIASV2_1567_ESMFold_hypothetical_protein	7lvh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7lvh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND N-[3-METHOXY-4-(1,3-OXAZOL-5-YL)PHENYL]-3-(PROPAN-2-YL)PIPERIDINE-2-CARBOXAMIDE	0.095	304	243	176	479	4	272	2.156E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7kia-assembly2.cif.gz_B Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 19	0.105	322	245	171	492	11	285	7.178E-04	95
LOKIASV2_1567_ESMFold_hypothetical_protein	3b8q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3b8q-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor	0.121	322	243	171	492	12	288	6.523E-04	95
LOKIASV2_1567_ESMFold_hypothetical_protein	6nsp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6nsp-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 9	0.105	308	251	180	487	11	291	2.739E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	7ybx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ybx-assembly1.cif.gz_A Crystal structure of FGFR4(V550M) kinase domain with 10z	0.122	312	255	171	482	4	295	6.523E-04	95
LOKIASV2_1567_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_A Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527	0.103	312	255	171	482	11	295	5.651E-04	95
LOKIASV2_1567_ESMFold_hypothetical_protein	4r7h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4r7h-assembly1.cif.gz_A Crystal structure of FMS KINASE domain with a small molecular inhibitor, PLX3397	0.108	316	248	171	486	29	307	1.337E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	8ao5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8ao5-assembly1.cif.gz_A Specific covalent inhibitor (6) of ERK2	0.126	238	140	166	403	1	161	4.635E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	4ifc-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4ifc-assembly2.cif.gz_B Crystal Structure of ADP-bound Human PRPF4B kinase domain	0.131	231	138	164	394	7	166	3.828E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fv5-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK9	0.102	327	240	165	491	6	273	9.564E-04	95
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fv9-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E71	0.093	324	257	165	488	7	290	8.286E-04	95
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qp9-assembly1.cif.gz_A Crystal Structure of ERK2 in complex with 7-(1-propyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine	0.114	229	136	166	394	3	157	9.497E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	2ghm-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2ghm-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-895449	0.115	228	134	180	407	20	171	5.612E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	8ao4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8ao4-assembly1.cif.gz_A Specific covalent inhibitor (5) of ERK2	0.100	332	294	165	492	4	335	6.523E-04	95
LOKIASV2_1567_ESMFold_hypothetical_protein	8x23-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8x23-assembly1.cif.gz_A The Crystal Structure of MAPK13 from Biortus.	0.100	230	149	170	399	4	170	2.739E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	3elj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3elj-assembly1.cif.gz_A Jnk1 complexed with a bis-anilino-pyrrolopyrimidine inhibitor.	0.141	138	110	172	300	1	138	6.795E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	1pmv-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1pmv-assembly1.cif.gz_A The structure of JNK3 in complex with a dihydroanthrapyrazole inhibitor	0.129	224	144	172	395	1	166	4.862E-03	95
LOKIASV2_1567_ESMFold_hypothetical_protein	6yvs-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6yvs-assembly3.cif.gz_C FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 5-{4-[(Pyridin-3-ylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one	0.121	197	156	180	358	9	205	1.698E-03	94
LOKIASV2_1567_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qho-assembly1.cif.gz_A Dual specificity mitogen-activated protein kinase kinase 7 in complex with pyrazolopyrimidine 1a	0.136	314	221	180	493	19	275	2.489E-03	94
LOKIASV2_1567_ESMFold_hypothetical_protein	6ib0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ib0-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3a	0.135	312	233	180	491	20	289	1.003E-03	94
LOKIASV2_1567_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4j96-assembly3.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.	0.117	319	247	174	492	20	300	7.530E-04	94
LOKIASV2_1567_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3tt0-assembly1.cif.gz_A Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)	0.107	315	256	168	482	11	298	5.928E-04	94
LOKIASV2_1567_ESMFold_hypothetical_protein	6il3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6il3-assembly1.cif.gz_A Crystal structure of the FLT3 kinase bound to a small molecule inhibitor	0.126	321	245	162	482	26	306	1.868E-03	94
LOKIASV2_1567_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	0.128	224	127	171	394	3	149	9.963E-03	94
LOKIASV2_1567_ESMFold_hypothetical_protein	4n4s-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4n4s-assembly2.cif.gz_B A Double Mutant Rat Erk2 in Complex With a Pyrazolo[3,4-d]pyrimidine Inhibitor	0.100	324	261	165	488	4	294	1.471E-03	94
LOKIASV2_1567_ESMFold_hypothetical_protein	5tf9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5tf9-assembly1.cif.gz_A Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	0.122	292	212	185	476	17	259	5.100E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	5ei6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ei6-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.098	312	235	176	487	1	262	2.262E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	0.123	319	220	171	489	11	262	1.543E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	4ymj-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4ymj-assembly2.cif.gz_B (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK Inhibitors	0.104	310	233	173	482	10	270	2.873E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	4c8b-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4c8b-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with ponatinib	0.105	312	235	180	491	11	274	1.781E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6p68-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 22.	0.103	309	238	174	482	16	281	1.104E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	0.101	323	248	171	493	10	286	7.899E-04	93
LOKIASV2_1567_ESMFold_hypothetical_protein	5o4a-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5o4a-assembly1.cif.gz_A Human FGF in complex with a covalent inhibitor	0.116	312	242	171	482	10	284	4.242E-04	93
LOKIASV2_1567_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7kie-assembly1.cif.gz_A Crystal structure of FGFR2 kinase domain gatekeeper mutant V564F in complex with covalent compound 3	0.096	312	254	171	482	5	286	1.337E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	2i0v-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2i0v-assembly1.cif.gz_A c-FMS tyrosine kinase in complex with a quinolone inhibitor	0.119	321	239	167	487	31	302	2.056E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	6mob-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6mob-assembly1.cif.gz_A Crystal structure of KIT1 in complex with DP2976 via co-crystallization	0.125	315	252	168	482	16	304	5.136E-04	93
LOKIASV2_1567_ESMFold_hypothetical_protein	3gqi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3gqi-assembly1.cif.gz_A Crystal Structure of activated receptor tyrosine kinase in complex with substrates	0.105	319	255	171	489	10	295	7.530E-04	93
LOKIASV2_1567_ESMFold_hypothetical_protein	8cgc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8cgc-assembly1.cif.gz_A Structure of CSF1R in complex with a pyrollopyrimidine (compound 23)	0.106	326	250	168	493	29	309	1.698E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	6fyv-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6fyv-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A	0.118	322	268	165	486	2	306	2.056E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	4iza-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4iza-assembly2.cif.gz_C Structure of Dually Phosphorylated ERK2 bound to the PEA-15 Death Effector Domain	0.083	232	145	165	396	3	161	6.478E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	8x5m-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8x5m-assembly1.cif.gz_A The Crystal Structure of JNK1 from Biortus.	0.144	130	101	171	300	16	134	9.054E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	2xrw-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2xrw-assembly1.cif.gz_A Linear binding motifs for JNK and for calcineurin antagonistically control the nuclear shuttling of NFAT4	0.132	307	226	180	486	26	286	9.117E-04	93
LOKIASV2_1567_ESMFold_hypothetical_protein	4y5h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4y5h-assembly1.cif.gz_A Pyridopyrimidinone Derivatives as Potent and Selective c-Jun N-Terminal Kinase (JNK) inhibitors	0.146	147	115	172	307	1	147	5.887E-03	93
LOKIASV2_1567_ESMFold_hypothetical_protein	5jrs-assembly3.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5jrs-assembly3.cif.gz_B CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	0.119	316	204	174	489	7	239	3.479E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4i-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4c4i-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.104	301	224	176	476	1	251	2.739E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	8edh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8edh-assembly1.cif.gz_A Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	0.128	279	197	174	452	9	235	5.100E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4js8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4js8-assembly1.cif.gz_A Crystal structure of TTK kinase domain with an inhibitor: 401348	0.110	310	217	176	485	2	246	3.649E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	8pm3-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	8pm3-assembly3.cif.gz_C Crystal structure of MAP2K6 with a covalent compound GCL94	0.132	321	234	169	489	1	271	1.960E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	3cjf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3cjf-assembly1.cif.gz_A Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine	0.113	315	237	171	485	13	280	2.873E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	5o4a-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5o4a-assembly2.cif.gz_B Human FGF in complex with a covalent inhibitor	0.108	312	243	171	482	14	286	3.675E-04	92
LOKIASV2_1567_ESMFold_hypothetical_protein	3lco-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3lco-assembly1.cif.gz_A Inhibitor Bound to A DFG-Out structure of the Kinase Domain of CSF-1R	0.109	319	245	168	486	17	292	3.828E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4tyg-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	0.116	315	240	171	485	20	292	3.855E-04	92
LOKIASV2_1567_ESMFold_hypothetical_protein	7zy6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7zy6-assembly1.cif.gz_A Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic or recurrent GIST	0.125	317	241	168	484	16	291	4.419E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5vnd-assembly3.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527	0.094	312	248	171	482	14	288	9.564E-04	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4ynz-assembly1.cif.gz_A Structure of the N-terminal domain of SAD	0.165	310	201	177	486	12	253	1.104E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	2ogv-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2ogv-assembly1.cif.gz_A Crystal Structure of the Autoinhibited Human c-Fms Kinase Domain	0.110	390	278	104	493	4	316	1.052E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	7nr9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7nr9-assembly1.cif.gz_A Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2	0.089	322	292	172	492	12	333	1.104E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	3c9w-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3c9w-assembly2.cif.gz_B Crystal Structure of ERK-2 with hypothemycin covalently bound	0.108	324	257	165	488	7	295	1.402E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	5ekn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ekn-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	0.079	221	149	172	392	5	167	5.100E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4x21-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4x21-assembly2.cif.gz_B The MAP kinase JNK3 as target for halogen bonding	0.125	223	130	171	393	14	162	4.635E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp8-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4qp8-assembly2.cif.gz_B Crystal Structure of ERK2 in complex with 2-(1H-pyrazol-4-yl)-7-(pyridin-3-yl)-5H-pyrrolo[2,3-b]pyrazine	0.100	229	139	166	394	3	157	9.497E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	6qa1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qa1-assembly1.cif.gz_A ERK2 mini-fragment binding	0.110	239	147	165	403	3	168	7.844E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	6q7k-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6q7k-assembly1.cif.gz_A ERK2 mini-fragment binding	0.108	224	136	180	403	18	171	1.265E-02	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E	LOKIASV2_1567_ESMFold_hypothetical_protein	4nif-assembly1.cif.gz_E Heterodimeric structure of ERK2 and RSK1	0.106	309	257	180	488	16	303	1.337E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4qtd-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qtd-assembly1.cif.gz_A Structure of human JNK1 in complex with SCH772984 and the AMPPNP-hydrolysed triphosphate revealing the second type-I binding mode	0.183	130	100	171	300	17	139	8.631E-03	92
LOKIASV2_1567_ESMFold_hypothetical_protein	4bi0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4bi0-assembly1.cif.gz_A Scaffold Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitor	0.114	296	220	176	471	1	249	2.489E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	5ap2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ap2-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.117	301	223	176	476	1	254	7.477E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	5n87-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5n87-assembly1.cif.gz_A TTK kinase domain in complex with NTRC 0066-0	0.118	296	221	176	471	1	251	2.373E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	6h3k-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6h3k-assembly1.cif.gz_A Introduction of a methyl group curbs metabolism of pyrido[3,4-d]pyrimidine MPS1 inhibitors and enables the discovery of the Phase 1 clinical candidate BOS172722.	0.096	312	230	176	487	1	255	3.161E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	5ehl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ehl-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.106	312	225	176	487	2	254	1.960E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	7aay-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7aay-assembly1.cif.gz_A Crystal structure of MerTK kinase domain in complex with Merestinib	0.100	312	229	171	482	15	269	1.471E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	7olv-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7olv-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole group	0.110	312	225	171	482	16	269	1.868E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	4uwy-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4uwy-assembly2.cif.gz_B FGFR1 Apo structure	0.096	312	230	171	482	15	269	1.960E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2psq-assembly1.cif.gz_A Crystal Structure of Unphosphorylated Unactivated Wild Type FGF Receptor 2 (FGFR2) Kinase Domain	0.118	323	245	171	493	9	287	1.618E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	6iup-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6iup-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with compound 5	0.106	303	240	180	482	16	285	9.117E-04	91
LOKIASV2_1567_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5flf-assembly2.cif.gz_B DISEASE LINKED MUTATION IN FGFR	0.098	312	245	171	482	14	286	6.843E-04	91
LOKIASV2_1567_ESMFold_hypothetical_protein	3g0f-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3g0f-assembly1.cif.gz_B KIT kinase domain mutant D816H in complex with sunitinib	0.129	315	237	168	482	19	291	3.828E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	8gmc-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8gmc-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.111	304	243	176	479	7	280	3.649E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	7yc3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7yc3-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain with 10t	0.117	312	257	171	482	4	295	7.899E-04	91
LOKIASV2_1567_ESMFold_hypothetical_protein	5eg3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5eg3-assembly1.cif.gz_A Crystal Structure of the Activated FGF Receptor 2 (FGFR2) Kinase Domain in complex with the cSH2 domain of Phospholipase C gamma (PLCgamma)	0.109	325	252	168	492	9	292	1.215E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2wel-assembly1.cif.gz_A Crystal structure of SU6656-bound calcium/calmodulin-dependent protein kinase II delta in complex with calmodulin	0.106	298	230	174	471	5	262	1.471E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	4xj0-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4xj0-assembly2.cif.gz_B Crystal structure of ERK2 in complex with an inhibitor 14K	0.105	332	293	165	492	3	334	1.698E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	4qny-assembly3.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4qny-assembly3.cif.gz_B Crystal structure of MapK from Leishmania donovani, LDBPK_331470	0.114	323	281	176	493	17	339	1.158E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	4oav-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	4oav-assembly1.cif.gz_D Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	0.104	285	175	198	482	346	541	1.698E-03	91
LOKIASV2_1567_ESMFold_hypothetical_protein	3cek-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3cek-assembly1.cif.gz_A Crystal structure of human dual specificity protein kinase (TTK)	0.114	310	211	176	485	2	240	2.873E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	5nad-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5nad-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1217389	0.100	318	213	176	493	1	238	2.739E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	6jol-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6jol-assembly1.cif.gz_A Crystal structure of PDGFRA in complex with imatinib by co-crystallization	0.150	313	230	171	483	6	277	5.100E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	2i0y-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2i0y-assembly1.cif.gz_A cFMS tyrosine kinase (FGF KID) in complex with an arylamide inhibitor	0.100	309	245	165	473	15	287	3.649E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.093	304	251	176	479	4	281	2.739E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_B Crystal structure of unactivated c-KIT in complex with compound	0.122	317	244	168	484	17	295	1.402E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	7zw8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7zw8-assembly1.cif.gz_A Identification of M4205 a highly selective inhibitor of cKIT mutations for unresectable metastatic or recurrent GIST	0.124	317	242	168	484	23	299	1.402E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	4i5h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4i5h-assembly1.cif.gz_A Crystal Structure of a Double Mutant Rat Erk2 Complexed With a Type II Quinazoline Inhibitor	0.092	131	111	170	300	10	132	9.054E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	4h39-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4h39-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with JIP1 Peptide	0.114	317	261	172	488	1	296	7.899E-04	90
LOKIASV2_1567_ESMFold_hypothetical_protein	4s30-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4s30-assembly1.cif.gz_A ERK2 intrinsically active mutant (I84A)	0.121	233	137	171	403	10	166	1.686E-02	90
LOKIASV2_1567_ESMFold_hypothetical_protein	3coi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3coi-assembly1.cif.gz_A Crystal structure of p38delta kinase	0.100	220	131	180	399	26	171	2.739E-03	90
LOKIASV2_1567_ESMFold_hypothetical_protein	4h36-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4h36-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with ATF2 Peptide	0.082	349	294	172	492	1	349	3.184E-04	90
LOKIASV2_1567_ESMFold_hypothetical_protein	5n93-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5n93-assembly1.cif.gz_A TTK kinase domain in complex with TC-Mps1-12	0.112	296	226	176	471	1	255	4.635E-03	89
LOKIASV2_1567_ESMFold_hypothetical_protein	6g3c-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6g3c-assembly2.cif.gz_B Crystal Structure of JAK2-V617F pseudokinase domain in complex with Compound 2	0.117	311	230	171	481	5	265	4.016E-03	89
LOKIASV2_1567_ESMFold_hypothetical_protein	5nud-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5nud-assembly2.cif.gz_B FIBROBLAST GROWTH FACTOR RECEPTOR 4 KINASE DOMAIN (449-753) IN COMPLEX WITH IRREVERSIBLE LIGAND CGA159527	0.116	309	220	174	482	19	268	7.899E-04	89
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fv6-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E57	0.089	309	249	180	488	17	290	2.373E-03	89
LOKIASV2_1567_ESMFold_hypothetical_protein	4qny-assembly3.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	4qny-assembly3.cif.gz_A-2 Crystal structure of MapK from Leishmania donovani, LDBPK_331470	0.117	318	279	176	493	17	333	2.873E-03	89
LOKIASV2_1567_ESMFold_hypothetical_protein	4aa5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4aa5-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 33	0.117	222	132	171	392	9	159	5.350E-03	89
LOKIASV2_1567_ESMFold_hypothetical_protein	5ke0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ke0-assembly1.cif.gz_A Discovery of 1-1H-Pyrazolo 4,3-c pyridine-6-yl urea Inhibitors of Extracellular Signal Regulated Kinase ERK for the Treatment of Cancers	0.095	334	291	170	492	3	336	9.117E-04	89
LOKIASV2_1567_ESMFold_hypothetical_protein	6yu1-assembly1.cif.gz_a	LOKIASV2_1567_ESMFold_hypothetical_protein	6yu1-assembly1.cif.gz_a CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	0.125	253	190	165	417	12	229	6.795E-03	89
LOKIASV2_1567_ESMFold_hypothetical_protein	6g9n-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6g9n-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	0.102	332	289	170	492	10	341	1.052E-03	89
LOKIASV2_1567_ESMFold_hypothetical_protein	6dtl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6dtl-assembly1.cif.gz_A Mitogen-activated protein kinase 6	0.119	216	156	181	396	3	180	2.489E-03	89
LOKIASV2_1567_ESMFold_hypothetical_protein	4c4h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4c4h-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.109	296	216	176	471	1	243	4.212E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	4riw-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4riw-assembly1.cif.gz_A Crystal structure of an EGFR/HER3 kinase domain heterodimer	0.098	308	228	180	487	11	264	1.698E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	5ew3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ew3-assembly1.cif.gz_A Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Kinase Domain in complex with AAL993	0.121	315	232	171	485	9	273	5.100E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_D FGFR2 in complex with YJ001	0.135	321	230	171	491	10	276	8.228E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H	LOKIASV2_1567_ESMFold_hypothetical_protein	2hak-assembly8.cif.gz_H Catalytic and ubiqutin-associated domains of MARK1/PAR-1	0.135	252	154	171	422	3	181	8.631E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B Crystal structure of MAP2K6 with a covalent compound GCL96	0.130	310	233	180	489	9	277	2.262E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	4uxq-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4uxq-assembly1.cif.gz_A FGFR4 in complex with Ponatinib	0.112	309	238	174	482	15	283	9.117E-04	88
LOKIASV2_1567_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3js2-assembly2.cif.gz_B Crystal structure of minimal kinase domain of fibroblast growth factor receptor 1 in complex with 5-(2-thienyl)nicotinic acid	0.102	312	244	171	482	15	287	1.052E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	5a46-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5a46-assembly2.cif.gz_B FGFR1 in complex with dovitinib	0.111	312	244	171	482	16	290	5.928E-04	88
LOKIASV2_1567_ESMFold_hypothetical_protein	4e73-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4e73-assembly1.cif.gz_A Crystal structure of JNK1beta-JIP in complex with an azaquinolone inhbitor	0.122	316	265	171	486	15	317	1.274E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_B Human PRPF4B bound to benzothiophene inhibitor 224	0.145	231	135	164	394	3	161	7.128E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp2-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4qp2-assembly2.cif.gz_B Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine	0.112	230	137	165	394	3	157	6.795E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly3.cif.gz_C Crystal structure of JNK1 bound to a MKK7 docking motif	0.100	313	276	180	487	19	331	3.161E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	6z2v-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6z2v-assembly1.cif.gz_A CLK3 A319V mutant bound with beta-carboline KH-CARB13 (Cpd 3)	0.120	325	262	165	489	13	311	2.873E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	7w5o-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7w5o-assembly2.cif.gz_B Crystal structure of ERK2 with an allosteric inhibitor	0.089	228	139	169	396	6	159	1.532E-02	88
LOKIASV2_1567_ESMFold_hypothetical_protein	3pze-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3pze-assembly1.cif.gz_A JNK1 in complex with inhibitor	0.119	321	252	171	491	16	302	1.003E-03	88
LOKIASV2_1567_ESMFold_hypothetical_protein	4z7h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4z7h-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	0.148	121	95	184	304	14	125	1.392E-02	88
LOKIASV2_1567_ESMFold_hypothetical_protein	6n6o-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6n6o-assembly1.cif.gz_A Crystal structure of the human TTK in complex with an inhibitor	0.116	318	206	176	493	2	235	3.649E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8b9e-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Z902-A3	0.122	310	231	172	481	7	270	6.795E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qft-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b	0.134	312	223	180	491	18	275	6.843E-04	87
LOKIASV2_1567_ESMFold_hypothetical_protein	4nk9-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4nk9-assembly1.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 1	0.111	312	232	171	482	14	275	3.479E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	4k33-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4k33-assembly1.cif.gz_A Crystal Structure of FGF Receptor 3 (FGFR3) Kinase Domain Harboring the K650E Mutation, a Gain-of-Function Mutation Responsible for Thanatophoric Dysplasia Type II and Spermatocytic Seminoma	0.114	312	249	171	482	9	290	1.274E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.107	304	246	176	479	9	285	5.612E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	4uwc-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4uwc-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P3	0.116	312	248	171	482	15	295	7.178E-04	87
LOKIASV2_1567_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I	LOKIASV2_1567_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	0.169	125	103	180	304	12	136	2.041E-02	87
LOKIASV2_1567_ESMFold_hypothetical_protein	1ukh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1ukh-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	0.107	319	276	175	484	2	320	1.402E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	3k3i-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3k3i-assembly1.cif.gz_A p38alpha bound to novel DGF-out compound PF-00215955	0.109	213	125	180	392	20	160	9.054E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	6fn5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6fn5-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.108	239	145	165	403	4	166	1.150E-02	87
LOKIASV2_1567_ESMFold_hypothetical_protein	3nnx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3nnx-assembly1.cif.gz_A Crystal structure of phosphorylated P38 alpha in complex with DP802	0.112	243	154	165	407	7	180	5.612E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	4g6o-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4g6o-assembly1.cif.gz_A Crystal Structure of the ERK2	0.095	234	141	170	403	10	166	1.769E-02	87
LOKIASV2_1567_ESMFold_hypothetical_protein	5ci6-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5ci6-assembly2.cif.gz_B Crystal structure of Arabidopsis thaliana MPK6	0.107	215	157	181	395	3	179	4.862E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	6yty-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6yty-assembly1.cif.gz_A CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)	0.126	321	250	165	485	20	306	2.873E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	7lv3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7lv3-assembly1.cif.gz_A Crystal structure of human protein kinase G (PKG) R-C complex in inhibited state	0.108	364	277	120	483	254	564	1.274E-03	87
LOKIASV2_1567_ESMFold_hypothetical_protein	5ei2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ei2-assembly1.cif.gz_A Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.113	298	224	176	473	1	253	4.635E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	3wzj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3wzj-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(6-(cyclohexylamino)-8-(((tetrahydro-2H-pyran-4-yl)methyl)amino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide	0.106	295	216	177	471	10	252	2.262E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	5n9s-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5n9s-assembly1.cif.gz_A TTK kinase domain in complex with BAY 1161909	0.114	318	213	176	493	1	241	4.635E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	2fgi-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	2fgi-assembly1.cif.gz_B CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF FGF RECEPTOR 1 IN COMPLEX WITH INHIBITOR PD173074	0.126	312	224	171	482	13	269	1.003E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	3rhx-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3rhx-assembly1.cif.gz_B Crystal structure of the catalytic domain of FGFR1 kinase in complex with ARQ 069	0.110	312	231	171	482	13	272	4.862E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly2.cif.gz_B Crystal structure of JNK1 bound to a MKK7 docking motif	0.100	307	272	180	482	19	325	4.016E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	3heg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3heg-assembly1.cif.gz_A P38 in complex with Sorafenib	0.120	214	124	180	393	20	161	1.265E-02	86
LOKIASV2_1567_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.155	229	138	169	397	13	176	4.419E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	5u6i-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5u6i-assembly1.cif.gz_A Discovery of MLi-2, an Orally Available and Selective LRRK2 Inhibitor that Reduces Brain Kinase Activity	0.100	224	137	180	403	8	160	1.265E-02	86
LOKIASV2_1567_ESMFold_hypothetical_protein	4eym-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4eym-assembly1.cif.gz_A MAPK13 complex with inhibitor	0.079	221	149	172	392	5	167	7.128E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	4zzo-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4zzo-assembly1.cif.gz_A Human ERK2 in complex with an irreversible inhibitor	0.097	329	291	170	492	10	338	1.960E-03	86
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp1-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4qp1-assembly2.cif.gz_B Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine	0.101	229	138	166	394	4	157	2.141E-02	86
LOKIASV2_1567_ESMFold_hypothetical_protein	5hbe-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5hbe-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH 8-[3-Chloro-5-(1-methyl-2,2-dioxo-2, 3-dihydro-1H-2l6-benzo[c]isothiazol-5-yl)-pyridin- 4-yl]-1-oxa-3,8-diaza-spiro[4.5]decan-2-one	0.154	116	96	185	300	27	141	4.388E-02	86
LOKIASV2_1567_ESMFold_hypothetical_protein	5r9d-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5r9d-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment S00888c in complex with MAP kinase p38-alpha	0.121	214	124	180	393	20	161	1.265E-02	86
LOKIASV2_1567_ESMFold_hypothetical_protein	4h3b-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4h3b-assembly2.cif.gz_C Crystal Structure of JNK3 in Complex with SAB Peptide	0.079	347	295	172	492	1	347	5.928E-04	86
LOKIASV2_1567_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_A Crystal structure of the kinase domain of ROR2	0.105	308	234	174	481	7	268	5.100E-03	85
LOKIASV2_1567_ESMFold_hypothetical_protein	4ymj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4ymj-assembly1.cif.gz_A (R)-2-Phenylpyrrolidine Substitute Imidazopyridazines: a New Class of Potent and Selective Pan-TRK Inhibitors	0.101	311	233	172	482	9	268	5.100E-03	85
LOKIASV2_1567_ESMFold_hypothetical_protein	5a46-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5a46-assembly1.cif.gz_A FGFR1 in complex with dovitinib	0.112	312	242	171	482	10	282	1.158E-03	85
LOKIASV2_1567_ESMFold_hypothetical_protein	4uwb-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4uwb-assembly2.cif.gz_B Fibroblast growth factor receptor 1 kinase in complex with JK-P5	0.127	323	245	171	493	15	296	9.564E-04	85
LOKIASV2_1567_ESMFold_hypothetical_protein	6gqk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6gqk-assembly1.cif.gz_A Crystal structure of human c-KIT kinase domain in complex with AZD3229-analogue (compound 23)	0.127	313	251	168	480	16	304	9.117E-04	85
LOKIASV2_1567_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 58	0.141	233	143	165	397	3	170	9.963E-03	85
LOKIASV2_1567_ESMFold_hypothetical_protein	5eko-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5eko-assembly1.cif.gz_A Crystal structure of MAPK13 complex with inhibitor	0.088	229	150	172	400	5	170	7.844E-03	85
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fv1-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK4	0.096	338	296	165	492	3	340	4.016E-03	85
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv7-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fv7-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with E94	0.111	335	290	166	492	5	339	2.156E-03	85
LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	4ux9-assembly4.cif.gz_D Crystal structure of JNK1 bound to a MKK7 docking motif	0.131	215	137	182	396	1	159	1.327E-02	85
LOKIASV2_1567_ESMFold_hypothetical_protein	3g90-assembly1.cif.gz_X	LOKIASV2_1567_ESMFold_hypothetical_protein	3g90-assembly1.cif.gz_X JNK-3 bound to (Z)-5-fluoro-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)indolin-2-one	0.148	134	107	174	300	2	135	1.532E-02	85
LOKIASV2_1567_ESMFold_hypothetical_protein	3r63-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3r63-assembly1.cif.gz_A Structure of ERK2 (SPE) mutant (S246E)	0.094	337	295	166	492	4	340	3.014E-03	85
LOKIASV2_1567_ESMFold_hypothetical_protein	5ap1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ap1-assembly1.cif.gz_A Naturally Occurring Mutations in the MPS1 Gene Predispose Cells to Kinase Inhibitor Drug Resistance.	0.109	296	235	176	471	2	266	4.419E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	8e1x-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8e1x-assembly1.cif.gz_A FGFR2 kinase domain in complex with a Pyrazolo[1,5-a]pyrimidine analog (Compound 29)	0.125	309	242	174	482	13	289	1.471E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	5xgn-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5xgn-assembly1.cif.gz_B Crystal structure of EGFR 696-1022 T790M/C797S in complex with Go6976	0.114	323	244	165	487	1	276	5.100E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6khd-assembly1.cif.gz_A Crystal structure of CLK1 in complex with CX-4945	0.124	322	259	165	486	3	299	2.156E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	6qx9-assembly1.cif.gz_K	LOKIASV2_1567_ESMFold_hypothetical_protein	6qx9-assembly1.cif.gz_K Structure of a human fully-assembled precatalytic spliceosome (pre-B complex).	0.149	230	135	165	394	2	161	1.045E-02	84
LOKIASV2_1567_ESMFold_hypothetical_protein	4f7j-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4f7j-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with compound 3 (1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-(2-hydroxyethyl)urea)	0.153	118	97	183	300	20	135	5.846E-02	84
LOKIASV2_1567_ESMFold_hypothetical_protein	4iir-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4iir-assembly1.cif.gz_A Crystal Structure of AMPPNP-bound Human PRPF4B kinase domain	0.132	208	132	187	394	15	167	1.769E-02	84
LOKIASV2_1567_ESMFold_hypothetical_protein	3da6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3da6-assembly1.cif.gz_A Crystal Structure of human JNK3 complexed with N-(3-methyl-4-(3-(2-(methylamino)pyrimidin-4-yl)pyridin-2-yloxy)naphthalen-1-yl)-1H-benzo[d]imidazol-2-amine	0.178	134	104	174	300	2	135	1.265E-02	84
LOKIASV2_1567_ESMFold_hypothetical_protein	1uki-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1uki-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	0.102	315	278	173	487	16	326	2.156E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	8aoe-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8aoe-assembly1.cif.gz_A Specific covalent inhibitor(15) of ERK2	0.118	239	137	165	403	4	159	9.497E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	6g9a-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6g9a-assembly1.cif.gz_A Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2	0.098	331	294	166	492	8	338	2.611E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	2zdt-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2zdt-assembly1.cif.gz_A Crystal Structure of human JNK3 complexed with an isoquinolone inhibitor	0.126	138	112	172	300	1	138	5.100E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	4s34-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4s34-assembly1.cif.gz_A ERK2 (I84A) in complex with AMP-PNP	0.101	325	255	167	491	5	289	2.489E-03	84
LOKIASV2_1567_ESMFold_hypothetical_protein	6yu1-assembly2.cif.gz_c	LOKIASV2_1567_ESMFold_hypothetical_protein	6yu1-assembly2.cif.gz_c CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	0.125	253	190	165	417	22	239	1.045E-02	84
LOKIASV2_1567_ESMFold_hypothetical_protein	6zr5-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6zr5-assembly2.cif.gz_B Crystal structure of JNK1 in complex with ATF2(19-58)	0.152	128	106	180	307	23	148	2.356E-02	84
LOKIASV2_1567_ESMFold_hypothetical_protein	6c18-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6c18-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37115	0.115	323	219	171	493	8	255	5.887E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	5eh0-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	5eh0-assembly1.cif.gz_A-2 Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle kinase 1 (MPS1) Using a Structure-Based Hydridization Approach	0.098	312	230	176	487	1	256	5.350E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	3wyx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3wyx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH 6-((3-(cyanomethoxy)-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-2-(cyclohexylamino)nicotinonitrile	0.120	296	221	176	471	1	252	7.477E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	0.125	303	193	185	487	17	237	7.844E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	6yg5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6yg5-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with ASC69	0.136	310	206	183	492	20	259	3.014E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	3brb-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3brb-assembly2.cif.gz_B Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex with ADP	0.124	314	228	171	484	8	268	1.052E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8xfl-assembly2.cif.gz_B The Crystal Structure of MARK4 from Biortus.	0.112	244	144	174	417	5	167	1.461E-02	83
LOKIASV2_1567_ESMFold_hypothetical_protein	3cjg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3cjg-assembly1.cif.gz_A Crystal structure of VEGFR2 in complex with a 3,4,5-trimethoxy aniline containing pyrimidine	0.120	312	231	174	485	18	281	3.828E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846	0.126	314	237	180	493	15	286	9.497E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	6xvj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6xvj-assembly1.cif.gz_A Crystal structure of the KDR (VEGFR2) kinase domain in complex with a type-II inhibitor	0.114	309	249	174	482	21	302	1.618E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	6ekd-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ekd-assembly1.cif.gz_A Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.127	313	244	174	486	2	281	1.215E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	8ao9-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8ao9-assembly1.cif.gz_A Specific covalent inhibitor(10) of ERK2	0.107	326	288	170	492	10	335	2.873E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qp1-assembly1.cif.gz_A Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine	0.100	332	293	166	492	4	335	3.479E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	8wgf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8wgf-assembly1.cif.gz_A The Crystal Structure of JNK3 from Biortus.	0.104	344	283	171	487	1	344	2.156E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	3cgf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3cgf-assembly1.cif.gz_A IRAK-4 Inhibitors (Part II)- A structure based assessment of imidazo[1,2 a]pyridine binding	0.094	345	285	172	487	1	345	2.262E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	0.100	307	252	175	481	2	282	3.161E-03	83
LOKIASV2_1567_ESMFold_hypothetical_protein	3wzk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3wzk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH N-cyclopropyl-4-(8-((thiophen-2-ylmethyl)amino)imidazo[1,2-a]pyrazin-3-yl)benzamide	0.106	312	228	176	487	1	256	8.631E-03	82
LOKIASV2_1567_ESMFold_hypothetical_protein	6tnc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6tnc-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 46	0.109	295	217	177	471	10	254	5.350E-03	82
LOKIASV2_1567_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4nka-assembly1.cif.gz_B Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2	0.113	312	234	171	482	16	280	2.873E-03	82
LOKIASV2_1567_ESMFold_hypothetical_protein	2qu5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2qu5-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a benzimidazole inhibitor	0.121	317	243	171	487	14	291	3.828E-03	82
LOKIASV2_1567_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.104	304	246	176	479	4	279	7.128E-03	82
LOKIASV2_1567_ESMFold_hypothetical_protein	5x02-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5x02-assembly1.cif.gz_A Crystal structure of the FLT3 kinase domain bound to the inhibitor FF-10101	0.114	329	248	154	482	21	301	4.862E-03	82
LOKIASV2_1567_ESMFold_hypothetical_protein	6khf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6khf-assembly1.cif.gz_A Crystal structure of CLK3 in complex with CX-4945	0.127	318	235	165	482	5	274	7.477E-03	82
LOKIASV2_1567_ESMFold_hypothetical_protein	4crl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4crl-assembly1.cif.gz_A Crystal structure of human CDK8-Cyclin C in complex with cortistatin A	0.148	116	95	185	300	29	141	8.571E-02	82
LOKIASV2_1567_ESMFold_hypothetical_protein	5r90-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5r90-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N11145a in complex with MAP kinase p38-alpha	0.118	214	123	180	393	21	161	2.246E-02	82
LOKIASV2_1567_ESMFold_hypothetical_protein	3v6s-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3v6s-assembly1.cif.gz_A Discovery of potent and selective covalent inhibitors of JNK	0.120	222	143	172	393	1	164	2.993E-02	82
LOKIASV2_1567_ESMFold_hypothetical_protein	4jt3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4jt3-assembly1.cif.gz_A Crystal Structure of TTK kinase domain with an inhibitor: 400740	0.115	292	211	180	471	11	249	6.795E-03	81
LOKIASV2_1567_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3zzw-assembly1.cif.gz_B Crystal structure of the kinase domain of ROR2	0.102	308	231	174	481	7	264	4.862E-03	81
LOKIASV2_1567_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	0.130	291	212	185	475	21	265	1.265E-02	81
LOKIASV2_1567_ESMFold_hypothetical_protein	5d7a-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	5d7a-assembly3.cif.gz_C Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846	0.134	309	235	180	488	13	284	1.265E-02	81
LOKIASV2_1567_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.123	305	173	174	478	2	199	7.477E-03	81
LOKIASV2_1567_ESMFold_hypothetical_protein	7clh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7clh-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 19	0.111	310	215	176	485	1	243	9.497E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	7aw2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7aw2-assembly1.cif.gz_A MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded library	0.106	312	224	171	482	15	266	5.887E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	4rix-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4rix-assembly2.cif.gz_C Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-Q790R mutation	0.094	308	235	180	487	11	270	5.100E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	5ax9-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	5ax9-assembly3.cif.gz_C Crystal structure of the kinase domain of human TRAF2 and NCK-interacting protein kinase in complex with compund 9	0.121	309	235	180	488	14	281	8.631E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8h75-assembly1.cif.gz_B FGFR2 in complex with YJ001	0.118	312	243	171	482	4	280	5.350E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	5cwz-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5cwz-assembly2.cif.gz_B Crystal structure of the kinase domain of human TRAF2 and NCK-interacting protein kinase	0.134	307	232	180	486	15	283	9.963E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	1xo2-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	1xo2-assembly1.cif.gz_B Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin	0.139	214	130	181	394	1	152	5.313E-02	80
LOKIASV2_1567_ESMFold_hypothetical_protein	7rj8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7rj8-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-(DIFLUOROM ETHOXY)-4-(1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.090	303	253	177	479	6	284	8.631E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	3vid-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vid-assembly1.cif.gz_A Crystal structure of human VEGFR2 kinase domain with Compound A.	0.127	312	242	174	485	21	298	1.868E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	6hh1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6hh1-assembly1.cif.gz_A Structure of c-Kit with allosteric inhibitor 3G8	0.124	315	249	168	482	18	302	1.618E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	4fuy-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fuy-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK2	0.104	322	286	171	492	8	327	3.828E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	5r99-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5r99-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13619a in complex with MAP kinase p38-alpha	0.122	213	123	180	392	20	160	2.141E-02	80
LOKIASV2_1567_ESMFold_hypothetical_protein	5awm-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5awm-assembly1.cif.gz_A The Crystal Structure of JNK from Drosophila melanogaster Reveals an Evolutionarily Conserved Topology with that of Mammalian JNK Proteins.	0.207	130	94	171	300	14	132	2.356E-02	80
LOKIASV2_1567_ESMFold_hypothetical_protein	4iz5-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4iz5-assembly2.cif.gz_B Structure of the complex between ERK2 phosphomimetic mutant and PEA-15	0.095	340	296	165	492	4	343	2.373E-03	80
LOKIASV2_1567_ESMFold_hypothetical_protein	2wqo-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2wqo-assembly1.cif.gz_A STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950	0.130	121	103	180	300	6	124	3.624E-02	79
LOKIASV2_1567_ESMFold_hypothetical_protein	6tnd-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6tnd-assembly1.cif.gz_A X-RAY STRUCTURE OF MPS1 IN COMPLEX WITH COMPOUND 79	0.126	294	216	176	469	1	248	9.497E-03	79
LOKIASV2_1567_ESMFold_hypothetical_protein	1vr2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1vr2-assembly1.cif.gz_A HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (KDR) KINASE DOMAIN	0.119	315	233	171	485	10	274	2.873E-03	79
LOKIASV2_1567_ESMFold_hypothetical_protein	4tye-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4tye-assembly1.cif.gz_A Structural analysis of the human Fibroblast Growth Factor Receptor 4 Kinase	0.111	312	244	171	482	12	286	4.016E-03	79
LOKIASV2_1567_ESMFold_hypothetical_protein	3vhk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vhk-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a back pocket binder	0.122	312	242	174	485	20	296	9.117E-04	79
LOKIASV2_1567_ESMFold_hypothetical_protein	8enj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8enj-assembly1.cif.gz_A Design, synthesis, biological evaluation, and X-ray crystallography of diarylpyrazole derivatives possessing terminal arylsulfonamide moieties as anti-proliferative agents targeting c-Jun N-terminal kinase (JNK)	0.106	331	281	172	486	1	331	1.003E-03	79
LOKIASV2_1567_ESMFold_hypothetical_protein	6qag-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qag-assembly1.cif.gz_A ERK2 mini-fragment binding	0.101	334	291	165	489	4	337	4.016E-03	79
LOKIASV2_1567_ESMFold_hypothetical_protein	6ytw-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6ytw-assembly1.cif.gz_A CLK3 bound with benzothiazole Tg003 (Cpd 2)	0.121	318	258	176	493	31	324	7.128E-03	79
LOKIASV2_1567_ESMFold_hypothetical_protein	4qrc-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qrc-assembly1.cif.gz_A Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 4 in Complex with Ponatinib	0.137	312	251	171	482	3	294	4.419E-03	78
LOKIASV2_1567_ESMFold_hypothetical_protein	3vnt-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vnt-assembly1.cif.gz_A Crystal Structure of the Kinase domain of Human VEGFR2 with a [1,3]thiazolo[5,4-b]pyridine derivative	0.113	315	249	171	485	19	300	1.618E-03	78
LOKIASV2_1567_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5kz8-assembly1.cif.gz_A Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.104	316	199	171	486	2	224	8.228E-03	78
LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_C Human PRPF4B bound to benzothiophene inhibitor 224	0.127	208	133	187	394	10	162	1.946E-02	78
LOKIASV2_1567_ESMFold_hypothetical_protein	4iir-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4iir-assembly2.cif.gz_B Crystal Structure of AMPPNP-bound Human PRPF4B kinase domain	0.148	231	134	164	394	7	164	8.631E-03	78
LOKIASV2_1567_ESMFold_hypothetical_protein	2b1p-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2b1p-assembly1.cif.gz_A inhibitor complex of JNK3	0.115	312	272	180	487	19	330	5.100E-03	78
LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly3.cif.gz_C Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.134	223	124	171	393	15	158	4.388E-02	78
LOKIASV2_1567_ESMFold_hypothetical_protein	6a32-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6a32-assembly1.cif.gz_A Crystal structure of PDGFRA kinase domain mutant T674I	0.136	315	245	167	481	32	316	1.698E-03	78
LOKIASV2_1567_ESMFold_hypothetical_protein	6rfp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6rfp-assembly1.cif.gz_A ERK2 MAP kinase with mutations at Helix-G	0.118	222	130	182	403	15	162	4.388E-02	78
LOKIASV2_1567_ESMFold_hypothetical_protein	3v6s-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3v6s-assembly2.cif.gz_B Discovery of potent and selective covalent inhibitors of JNK	0.108	340	282	172	488	1	340	3.161E-03	78
LOKIASV2_1567_ESMFold_hypothetical_protein	5o21-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5o21-assembly2.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated state with chloride bound in the active site	0.126	306	205	185	490	18	252	1.265E-02	77
LOKIASV2_1567_ESMFold_hypothetical_protein	7sj3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7sj3-assembly1.cif.gz_A Structure of CDK4-Cyclin D3 bound to abemaciclib	0.109	220	127	175	394	3	145	6.433E-02	77
LOKIASV2_1567_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.096	304	250	176	479	4	280	1.150E-02	77
LOKIASV2_1567_ESMFold_hypothetical_protein	2oh4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2oh4-assembly1.cif.gz_A Crystal structure of Vegfr2 with a benzimidazole-urea inhibitor	0.113	315	249	171	485	14	295	3.161E-03	77
LOKIASV2_1567_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5kz8-assembly2.cif.gz_B Mark2 complex with 7-[(1S)-1-(4-fluorophenyl)ethyl]-5,5-dimethyl-2-(3-pyridylamino)pyrrolo[2,3-d]pyrimidin-6-one	0.101	316	198	171	486	2	222	6.795E-03	77
LOKIASV2_1567_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6itt-assembly1.cif.gz_A Crystal structure of unactivated c-KIT in complex with compound	0.126	326	246	168	493	20	301	3.161E-03	77
LOKIASV2_1567_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7n91-assembly2.cif.gz_B P70 S6K1 IN COMPLEX WITH MSC2317067A-1	0.158	315	225	169	483	1	268	1.327E-02	77
LOKIASV2_1567_ESMFold_hypothetical_protein	6dcg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6dcg-assembly1.cif.gz_A Discovery of MK-8353: An Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology	0.089	317	281	180	489	8	324	1.150E-02	77
LOKIASV2_1567_ESMFold_hypothetical_protein	4f70-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4f70-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with compound 4 (1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[2-(morpholin-4-yl)ethyl]urea)	0.148	116	95	185	300	27	139	1.198E-01	77
LOKIASV2_1567_ESMFold_hypothetical_protein	3oy1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3oy1-assembly1.cif.gz_A Highly Selective c-Jun N-Terminal Kinase (JNK) 2 and 3 Inhibitors with In Vitro CNS-like Pharmacokinetic Properties	0.121	317	275	171	487	15	328	2.739E-03	77
LOKIASV2_1567_ESMFold_hypothetical_protein	2exc-assembly1.cif.gz_X	LOKIASV2_1567_ESMFold_hypothetical_protein	2exc-assembly1.cif.gz_X Inhibitor complex of JNK3	0.146	135	109	172	300	1	135	2.356E-02	77
LOKIASV2_1567_ESMFold_hypothetical_protein	2xs0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2xs0-assembly1.cif.gz_A Linear binding motifs for JNK and for calcineurin antagonistically control the nuclear shuttling of NFAT4	0.126	317	197	171	487	17	242	4.635E-03	77
LOKIASV2_1567_ESMFold_hypothetical_protein	6gl3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6gl3-assembly1.cif.gz_A Crystal structure of human Phosphatidylinositol 4-kinase III beta (PI4KIIIbeta) in complex with ligand 44	0.125	362	291	130	491	19	351	9.564E-04	77
LOKIASV2_1567_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5i4n-assembly1.cif.gz_A Crystal Structure of the E596A V617F Mutant JAK2 Pseudokinase Domain Bound to Mg-ATP	0.131	312	233	172	483	6	274	2.873E-03	76
LOKIASV2_1567_ESMFold_hypothetical_protein	3b2t-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3b2t-assembly1.cif.gz_B Structure of phosphotransferase	0.095	321	241	171	491	20	286	4.635E-03	76
LOKIASV2_1567_ESMFold_hypothetical_protein	3k3j-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3k3j-assembly1.cif.gz_A P38alpha bound to novel DFG-out compound PF-00416121	0.111	214	124	180	393	20	159	1.686E-02	76
LOKIASV2_1567_ESMFold_hypothetical_protein	2ok1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2ok1-assembly1.cif.gz_A Crystal structure of JNK3 bound to N-benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide	0.141	134	108	174	300	2	135	3.140E-02	76
LOKIASV2_1567_ESMFold_hypothetical_protein	6qal-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qal-assembly1.cif.gz_A ERK2 mini-fragment binding	0.110	328	290	166	492	5	332	5.612E-03	76
LOKIASV2_1567_ESMFold_hypothetical_protein	4gsb-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4gsb-assembly1.cif.gz_A Monoclinic crystal form of the apo-ERK2	0.095	331	288	171	489	11	341	6.176E-03	76
LOKIASV2_1567_ESMFold_hypothetical_protein	5hd7-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5hd7-assembly1.cif.gz_A Dissecting Therapeutic Resistance to ERK Inhibition Rat Mutant SCH772984 in complex with (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide	0.100	342	294	165	492	2	343	7.128E-03	76
LOKIASV2_1567_ESMFold_hypothetical_protein	5o2c-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5o2c-assembly1.cif.gz_A Crystal structure of WNK3 kinase and CCT1 didomain in a unphosphorylated state	0.117	306	207	185	490	24	258	5.887E-03	76
LOKIASV2_1567_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_D Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.129	318	202	174	491	7	239	2.472E-02	75
LOKIASV2_1567_ESMFold_hypothetical_protein	2w5h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2w5h-assembly1.cif.gz_A Human Nek2 kinase Apo	0.093	307	210	180	486	6	238	7.844E-03	75
LOKIASV2_1567_ESMFold_hypothetical_protein	7qhg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7qhg-assembly1.cif.gz_A LIM domain kinase 2 (LIMK2) in complex with TH-470	0.101	308	252	178	485	1	281	2.720E-02	75
LOKIASV2_1567_ESMFold_hypothetical_protein	4f0i-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4f0i-assembly2.cif.gz_B Crystal structure of apo TrkA	0.107	311	248	172	482	7	285	3.316E-03	75
LOKIASV2_1567_ESMFold_hypothetical_protein	3wze-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3wze-assembly1.cif.gz_A KDR in complex with ligand sorafenib	0.120	309	243	174	482	19	295	3.316E-03	75
LOKIASV2_1567_ESMFold_hypothetical_protein	3vhe-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vhe-assembly1.cif.gz_A Crystal structure of human VEGFR2 kinase domain with a novel pyrrolopyrimidine inhibitor.	0.122	312	244	174	485	23	301	2.739E-03	75
LOKIASV2_1567_ESMFold_hypothetical_protein	3vo3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3vo3-assembly1.cif.gz_A Crystal Structure of the Kinase domain of Human VEGFR2 with imidazo[1,2-b]pyridazine derivative	0.123	312	246	174	485	22	302	2.611E-03	75
LOKIASV2_1567_ESMFold_hypothetical_protein	7ksk-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ksk-assembly1.cif.gz_A Thiophenyl-Pyrazolourea Derivatives as Potent, Brian Penetrant, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors	0.104	332	281	172	486	1	332	7.844E-03	75
LOKIASV2_1567_ESMFold_hypothetical_protein	6joj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6joj-assembly1.cif.gz_A Crystal structure of PDGFRA T674I in complex with crenolanib by soaking	0.134	322	255	171	492	35	329	1.698E-03	75
LOKIASV2_1567_ESMFold_hypothetical_protein	3g9n-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3g9n-assembly1.cif.gz_A JNK3 bound to (Z)-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)-4-phenylindolin-2-one	0.127	222	141	172	393	1	163	3.801E-02	75
LOKIASV2_1567_ESMFold_hypothetical_protein	7mp8-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	7mp8-assembly1.cif.gz_A-2 Crystal structure of the cytosolic domain of Tribolium castaneum PINK1 in the non-phosphorylated state	0.086	377	330	129	490	1	377	3.161E-03	75
LOKIASV2_1567_ESMFold_hypothetical_protein	2pk9-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	2pk9-assembly3.cif.gz_C Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway	0.135	183	92	214	396	15	121	1.257E-01	74
LOKIASV2_1567_ESMFold_hypothetical_protein	3b8r-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3b8r-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor	0.114	322	242	171	492	12	285	7.128E-03	74
LOKIASV2_1567_ESMFold_hypothetical_protein	2i1m-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2i1m-assembly1.cif.gz_A cFMS tyrosine kinase (tie2 KID) in complex with an arylamide inhibitor	0.116	329	254	165	493	24	311	5.887E-03	74
LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_D Human PRPF4B bound to benzothiophene inhibitor 224	0.139	208	129	187	394	6	156	2.041E-02	74
LOKIASV2_1567_ESMFold_hypothetical_protein	4dlj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4dlj-assembly1.cif.gz_A Human p38 MAP kinase in complex with RL163	0.093	307	278	180	486	21	327	7.477E-03	74
LOKIASV2_1567_ESMFold_hypothetical_protein	7pvu-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7pvu-assembly2.cif.gz_B Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	0.103	309	274	180	486	20	328	5.612E-03	74
LOKIASV2_1567_ESMFold_hypothetical_protein	6jok-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6jok-assembly1.cif.gz_A Crystal structure of PDGFRA in complex with sunitinib by soaking	0.157	322	250	171	492	33	329	1.960E-03	74
LOKIASV2_1567_ESMFold_hypothetical_protein	4qp6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qp6-assembly1.cif.gz_A Crystal Structure of ERK2 in complex with 5H-pyrrolo[2,3-b]pyrazine	0.103	319	256	170	488	9	294	9.963E-03	74
LOKIASV2_1567_ESMFold_hypothetical_protein	6sgi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6sgi-assembly1.cif.gz_A Nek2 kinase bound to inhibitor 96	0.083	313	202	174	486	5	225	1.265E-02	73
LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly3.cif.gz_C Crystal structure of JNK in complex with a regulator protein	0.144	130	100	171	300	10	127	6.133E-02	73
LOKIASV2_1567_ESMFold_hypothetical_protein	5ax3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5ax3-assembly1.cif.gz_A Crystal structure of ERK2 complexed with allosteric and ATP-competitive inhibitors.	0.109	231	137	166	396	6	160	4.828E-02	73
LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly2.cif.gz_B Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.148	214	118	180	393	19	157	7.079E-02	73
LOKIASV2_1567_ESMFold_hypothetical_protein	6zr5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6zr5-assembly1.cif.gz_A Crystal structure of JNK1 in complex with ATF2(19-58)	0.114	307	234	180	486	24	288	5.887E-03	73
LOKIASV2_1567_ESMFold_hypothetical_protein	5oat-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	5oat-assembly1.cif.gz_D PINK1 structure	0.131	144	113	170	300	2	145	2.853E-02	73
LOKIASV2_1567_ESMFold_hypothetical_protein	7mp9-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	7mp9-assembly1.cif.gz_A-2 Crystal structure of the cytosolic domain of Tribolium castaneum PINK1 phosphorylated at Ser205 in complex with ADP analog	0.117	180	151	129	300	1	180	1.461E-02	73
LOKIASV2_1567_ESMFold_hypothetical_protein	6yg4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6yg4-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) in complex with K00007	0.135	311	209	183	493	18	260	3.014E-03	72
LOKIASV2_1567_ESMFold_hypothetical_protein	7uos-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7uos-assembly1.cif.gz_A Structure of WNK1 inhibitor complex	0.148	127	103	174	300	9	130	3.988E-02	72
LOKIASV2_1567_ESMFold_hypothetical_protein	7ovl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ovl-assembly1.cif.gz_A Protein kinase MKK7 in complex with methoxycyclohexyl-substituted indazole	0.137	311	224	183	493	19	278	9.497E-03	72
LOKIASV2_1567_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_A Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	0.089	302	218	181	482	14	253	3.293E-02	72
LOKIASV2_1567_ESMFold_hypothetical_protein	6d22-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6d22-assembly1.cif.gz_A Crystal structure of Tyrosine-protein kinase receptor	0.107	313	250	170	482	10	290	3.316E-03	72
LOKIASV2_1567_ESMFold_hypothetical_protein	3u6j-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3u6j-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with a pyrazolone inhibitor	0.115	318	256	171	488	15	304	2.056E-03	72
LOKIASV2_1567_ESMFold_hypothetical_protein	6sgh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6sgh-assembly1.cif.gz_A Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 66	0.107	153	127	183	325	6	158	1.946E-02	71
LOKIASV2_1567_ESMFold_hypothetical_protein	6vg3-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6vg3-assembly3.cif.gz_C Structure of unliganded, inactive PTK7 kinase domain	0.110	317	231	171	487	4	264	2.593E-02	71
LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly1.cif.gz_E	LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly1.cif.gz_E Crystal structure of JNK in complex with a regulator protein	0.153	128	103	180	307	20	142	6.133E-02	71
LOKIASV2_1567_ESMFold_hypothetical_protein	8aob-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8aob-assembly1.cif.gz_A Specific covalent inhibitor(12) of ERK2	0.109	204	122	200	403	15	152	9.432E-02	71
LOKIASV2_1567_ESMFold_hypothetical_protein	4hvs-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4hvs-assembly1.cif.gz_A Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX647	0.142	313	249	168	480	35	325	5.100E-03	71
LOKIASV2_1567_ESMFold_hypothetical_protein	6fxv-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6fxv-assembly1.cif.gz_A Crystal structure of ERK2 in complex with an adenosine derivative	0.098	326	290	171	492	9	334	1.946E-02	71
LOKIASV2_1567_ESMFold_hypothetical_protein	1pmu-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1pmu-assembly1.cif.gz_A The crystal structure of JNK3 in complex with a phenantroline inhibitor	0.111	222	145	172	393	1	164	3.455E-02	71
LOKIASV2_1567_ESMFold_hypothetical_protein	8q6h-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8q6h-assembly1.cif.gz_A HUMAN PI4KIIIB IN COMPLEX WITH COVALENTLY BOUND INHIBITOR (COMPOUND 11)	0.126	357	292	135	491	29	363	8.286E-04	71
LOKIASV2_1567_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	0.128	302	170	180	481	8	203	7.789E-02	70
LOKIASV2_1567_ESMFold_hypothetical_protein	6qg4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qg4-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1h	0.152	309	214	183	491	18	270	2.873E-03	70
LOKIASV2_1567_ESMFold_hypothetical_protein	6rfo-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6rfo-assembly1.cif.gz_A ERK2 MAP kinase with the activation loop of p38alpha	0.110	325	278	165	489	1	313	1.686E-02	70
LOKIASV2_1567_ESMFold_hypothetical_protein	3rtp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3rtp-assembly1.cif.gz_A Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration	0.115	315	258	174	488	2	293	1.206E-02	70
LOKIASV2_1567_ESMFold_hypothetical_protein	3fl4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3fl4-assembly1.cif.gz_A P38 kinase crystal structure in complex with RO5634	0.117	214	123	180	393	21	160	4.183E-02	70
LOKIASV2_1567_ESMFold_hypothetical_protein	5hnb-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5hnb-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH [6-Hydroxy-3-(3-methyl-benzyl)-1H-indazol-5-yl]-((S)-3-hydroxy-pyrrolidin-1-yl)-methanone	0.144	173	120	128	300	1	141	5.573E-02	70
LOKIASV2_1567_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.109	292	221	198	489	15	263	1.946E-02	70
LOKIASV2_1567_ESMFold_hypothetical_protein	5ew3-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5ew3-assembly2.cif.gz_B Human Vascular Endothelial Growth Factor Receptor 2 (KDR) Kinase Domain in complex with AAL993	0.119	312	225	171	482	10	265	9.497E-03	69
LOKIASV2_1567_ESMFold_hypothetical_protein	5di1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5di1-assembly1.cif.gz_A MAP4K4 in complex with an inhibitor	0.121	309	238	180	488	13	284	3.624E-02	69
LOKIASV2_1567_ESMFold_hypothetical_protein	5uv4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5uv4-assembly1.cif.gz_A Crystal Structure of Maize SIRK1 (sucrose-induced receptor kinase 1) kinase domain bound to AMP-PNP	0.116	300	237	182	481	20	288	5.065E-02	69
LOKIASV2_1567_ESMFold_hypothetical_protein	8j5w-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8j5w-assembly1.cif.gz_A The crystal structure of TrkA(F589L) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-4^6-methyl-14-oxo-5-oxa-13-aza-1(3,6)-imidazo[1,2-b]pyridazina-4(1,3)-benzenacyclotetradecaphan-2-yne-4^5-carboxamide	0.114	316	250	172	487	14	296	3.649E-03	69
LOKIASV2_1567_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A X-ray structure of p38alpha bound to VX-745	0.090	316	277	171	486	15	319	9.054E-03	69
LOKIASV2_1567_ESMFold_hypothetical_protein	4fv4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4fv4-assembly1.cif.gz_A Crystal Structure of the ERK2 complexed with EK7	0.096	310	238	180	489	17	280	9.963E-03	69
LOKIASV2_1567_ESMFold_hypothetical_protein	4z7h-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4z7h-assembly2.cif.gz_B Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	0.119	292	215	176	467	1	245	3.801E-02	69
LOKIASV2_1567_ESMFold_hypothetical_protein	4u42-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4u42-assembly2.cif.gz_A MAP4K4 T181E Mutant Bound to inhibitor compound 1	0.125	309	236	180	488	10	280	3.988E-02	68
LOKIASV2_1567_ESMFold_hypothetical_protein	5y90-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5y90-assembly1.cif.gz_A MAP2K7 mutant -C218S	0.131	313	234	180	492	18	287	6.478E-03	68
LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6pjj-assembly1.cif.gz_A Human PRPF4B bound to benzothiophene inhibitor 224	0.140	231	132	164	394	3	157	4.388E-02	68
LOKIASV2_1567_ESMFold_hypothetical_protein	1t45-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1t45-assembly1.cif.gz_A STRUCTURAL BASIS FOR THE AUTOINHIBITION AND STI-571 INHIBITION OF C-KIT TYROSINE KINASE	0.117	321	260	168	488	36	330	3.014E-03	68
LOKIASV2_1567_ESMFold_hypothetical_protein	4z9l-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4z9l-assembly1.cif.gz_A THE STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR	0.098	332	284	172	487	1	332	1.215E-03	68
LOKIASV2_1567_ESMFold_hypothetical_protein	4qpa-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4qpa-assembly2.cif.gz_B Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine	0.100	309	258	180	488	14	301	2.853E-02	68
LOKIASV2_1567_ESMFold_hypothetical_protein	7ovn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ovn-assembly1.cif.gz_A Protein kinase MKK7 in complex with tolyl-substituted indazole	0.134	314	228	180	493	19	282	1.265E-02	67
LOKIASV2_1567_ESMFold_hypothetical_protein	4u43-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4u43-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 6)	0.117	309	240	180	488	12	284	1.769E-02	67
LOKIASV2_1567_ESMFold_hypothetical_protein	3c7q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3c7q-assembly1.cif.gz_A Structure of VEGFR2 kinase domain in complex with BIBF1120	0.123	312	239	174	485	15	287	1.045E-02	67
LOKIASV2_1567_ESMFold_hypothetical_protein	4kkh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4kkh-assembly1.cif.gz_A The crystal structure of inhibitor-bound JNK3	0.109	350	281	172	487	1	350	2.056E-03	67
LOKIASV2_1567_ESMFold_hypothetical_protein	5o1v-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5o1v-assembly1.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated apo state (A-loop swapped)	0.152	116	97	185	300	19	133	8.991E-02	66
LOKIASV2_1567_ESMFold_hypothetical_protein	6pl3-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6pl3-assembly1.cif.gz_A TRK-A IN COMPLEX WITH LIGAND 2a	0.104	303	242	180	482	11	281	1.532E-02	66
LOKIASV2_1567_ESMFold_hypothetical_protein	2xir-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2xir-assembly1.cif.gz_A Crystal structure of the VEGFR2 kinase domain in complex with PF- 00337210 (N,2-dimethyl-6-(7-(2-morpholinoethoxy)quinolin-4-yloxy) benzofuran-3-carboxamide)	0.116	315	248	171	485	14	295	5.350E-03	66
LOKIASV2_1567_ESMFold_hypothetical_protein	6cpw-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6cpw-assembly1.cif.gz_A Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology	0.100	320	278	180	489	6	325	2.472E-02	66
LOKIASV2_1567_ESMFold_hypothetical_protein	3oht-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3oht-assembly1.cif.gz_B Crystal Structure of Salmo Salar p38alpha	0.106	311	222	180	490	21	269	2.141E-02	66
LOKIASV2_1567_ESMFold_hypothetical_protein	6eq9-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6eq9-assembly2.cif.gz_B Crystal structure of JNK3 in complex with AMP-PCP	0.112	316	236	171	486	14	280	1.327E-02	66
LOKIASV2_1567_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.134	303	171	180	482	8	206	2.472E-02	65
LOKIASV2_1567_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4tpt-assembly1.cif.gz_B Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	0.109	277	165	198	474	16	201	5.573E-02	64
LOKIASV2_1567_ESMFold_hypothetical_protein	6cnh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6cnh-assembly1.cif.gz_A Human PRPF4B in complex with Rebastinib	0.119	302	194	154	455	3	223	1.265E-02	64
LOKIASV2_1567_ESMFold_hypothetical_protein	3hv7-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3hv7-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL38	0.104	303	174	180	482	20	214	1.946E-02	64
LOKIASV2_1567_ESMFold_hypothetical_protein	2dyl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2dyl-assembly1.cif.gz_A Crystal structure of human mitogen-activated protein kinase kinase 7 activated mutant (S287D, T291D)	0.141	309	216	183	491	18	269	4.388E-02	63
LOKIASV2_1567_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1kv1-assembly1.cif.gz_A p38 MAP Kinase in Complex with Inhibitor 1	0.097	310	277	180	489	20	327	1.327E-02	63
LOKIASV2_1567_ESMFold_hypothetical_protein	8j5x-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8j5x-assembly1.cif.gz_A The crystal structure of TrkA(G595R) kinase in complex with N-(3-cyclopropyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-4^6-methyl-14-oxo-5-oxa-13-aza-1(3,6)-imidazo[1,2-b]pyridazina-4(1,3)-benzenacyclotetradecaphan-2-yne-4^5-carboxamide	0.117	311	245	172	482	8	286	1.327E-02	62
LOKIASV2_1567_ESMFold_hypothetical_protein	6hkm-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6hkm-assembly1.cif.gz_A Crystal structure of Compound 1 with ERK5	0.114	322	276	180	492	2	323	3.988E-02	62
LOKIASV2_1567_ESMFold_hypothetical_protein	2zdu-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2zdu-assembly1.cif.gz_A Crystal Structure of human JNK3 complexed with an isoquinolone inhibitor	0.105	328	280	174	487	2	329	4.016E-03	62
LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	6emh-assembly4.cif.gz_D Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.111	317	198	171	487	15	238	3.988E-02	62
LOKIASV2_1567_ESMFold_hypothetical_protein	3g9l-assembly1.cif.gz_X	LOKIASV2_1567_ESMFold_hypothetical_protein	3g9l-assembly1.cif.gz_X JNK3 bound to (Z)-1-((6-fluoro-4H-benzo[d][1,3]dioxin-8-yl)methyl)-3-(hydroxyimino)-4-styrylindolin-2-one	0.157	131	106	174	300	2	132	1.038E-01	62
LOKIASV2_1567_ESMFold_hypothetical_protein	5n68-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5n68-assembly1.cif.gz_A Crystal Structure of p38alpha in Complex with Lipid Pocket Ligand 9m	0.084	307	276	180	486	21	322	2.356E-02	61
LOKIASV2_1567_ESMFold_hypothetical_protein	4u79-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4u79-assembly1.cif.gz_A Crystal structure of human JNK3 in complex with a benzenesulfonamide inhibitor.	0.097	336	285	171	487	1	336	5.350E-03	61
LOKIASV2_1567_ESMFold_hypothetical_protein	6yg1-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6yg1-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) in an active state, allosterically triggered by the N-terminal helix	0.131	307	236	183	489	28	300	1.150E-02	60
LOKIASV2_1567_ESMFold_hypothetical_protein	6s76-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6s76-assembly1.cif.gz_A Crystal structure of human Nek7	0.161	207	158	174	362	13	219	5.065E-02	58
LOKIASV2_1567_ESMFold_hypothetical_protein	8bzp-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8bzp-assembly2.cif.gz_B JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	0.125	307	225	180	486	16	273	5.313E-02	58
LOKIASV2_1567_ESMFold_hypothetical_protein	6zwp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6zwp-assembly1.cif.gz_A p38a bound with SR348	0.082	316	278	171	486	17	320	2.993E-02	58
LOKIASV2_1567_ESMFold_hypothetical_protein	6f5e-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6f5e-assembly1.cif.gz_B Crystal structure of DARPin-DARPin rigid fusion, variant DD_D12_10_47 in complex JNK1a1 and JIP1 peptide	0.112	306	215	182	487	3	245	3.801E-02	57
LOKIASV2_1567_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3soa-assembly1.cif.gz_A Full-length human CaMKII	0.096	309	253	173	481	5	285	4.183E-02	57
LOKIASV2_1567_ESMFold_hypothetical_protein	6qfr-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qfr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 dfg-out conformation	0.136	307	212	183	489	19	264	1.461E-02	56
LOKIASV2_1567_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7cbx-assembly1.cif.gz_A Crystal structure of MAP2K7 complexed with a covalent inhibitor 12	0.133	310	226	183	492	18	279	2.141E-02	56
LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly2.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4yr8-assembly2.cif.gz_A Crystal structure of JNK in complex with a regulator protein	0.105	316	271	171	486	15	318	6.133E-02	56
LOKIASV2_1567_ESMFold_hypothetical_protein	4qpa-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4qpa-assembly1.cif.gz_A Crystal Structure of ERK2 in complex with 7-(1-benzyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine	0.095	215	129	180	394	11	154	4.357E-01	55
LOKIASV2_1567_ESMFold_hypothetical_protein	8ow2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8ow2-assembly1.cif.gz_A Crystal structure of the p110alpha catalytic subunit from homo sapiens in complex with activator 1938	0.103	316	229	177	492	631	886	2.356E-02	55
LOKIASV2_1567_ESMFold_hypothetical_protein	3ub1-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3ub1-assembly2.cif.gz_B Ntf2 like protein involved in plasmid conjugation	0.090	186	167	36	221	51	234	4.183E-02	53
LOKIASV2_1567_ESMFold_hypothetical_protein	3l8x-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	3l8x-assembly1.cif.gz_A P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor	0.095	316	281	176	486	4	319	4.603E-02	51
LOKIASV2_1567_ESMFold_hypothetical_protein	5hvy-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5hvy-assembly1.cif.gz_A CDK8/CYCC IN COMPLEX WITH COMPOUND 20	0.127	173	118	128	300	1	136	2.972E-01	51
LOKIASV2_1567_ESMFold_hypothetical_protein	8ts8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8ts8-assembly1.cif.gz_A p85alpha/p110alpha heterodimer H1047R mutant	0.101	316	241	177	492	715	983	4.183E-02	51
LOKIASV2_1567_ESMFold_hypothetical_protein	3f14-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	3f14-assembly1.cif.gz_A-2 Crystal structure of NTF2-like protein of unknown function (YP_680363.1) from CYTOPHAGA HUTCHINSONII ATCC 33406 at 1.45 A resolution	0.145	48	37	174	221	58	101	3.096E+00	48
LOKIASV2_1567_ESMFold_hypothetical_protein	2bo9-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	2bo9-assembly1.cif.gz_D Human carboxypeptidase A4 in complex with human latexin.	0.085	186	158	36	221	32	205	1.532E-02	48
LOKIASV2_1567_ESMFold_hypothetical_protein	6pys-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6pys-assembly1.cif.gz_A Human PI3Kalpha in complex with Compound 2-10 ((3S)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2H-indol-2-one)	0.100	361	292	132	492	553	877	6.433E-02	47
LOKIASV2_1567_ESMFold_hypothetical_protein	5aig-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5aig-assembly2.cif.gz_B Discovery and characterization of thermophilic limonene-1,2-epoxide hydrolases from hot spring metagenomic libraries. Tomsk-sample- Valpromide complex	0.043	45	41	38	81	57	101	1.440E+00	46
LOKIASV2_1567_ESMFold_hypothetical_protein	5z3r-assembly4.cif.gz_E	LOKIASV2_1567_ESMFold_hypothetical_protein	5z3r-assembly4.cif.gz_E Crystal Structure of Delta 5-3-Ketosteroid Isomerase from Mycobacterium sp.	0.106	46	40	36	81	66	111	2.814E+00	46
LOKIASV2_1567_ESMFold_hypothetical_protein	8exl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8exl-assembly1.cif.gz_A Crystal structure of PI3K-alpha in complex with taselisib	0.105	316	234	177	492	617	879	1.089E-01	46
LOKIASV2_1567_ESMFold_hypothetical_protein	8exu-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8exu-assembly1.cif.gz_A Crystal structure of PI3K-alpha in complex with compound 30	0.106	316	235	177	492	622	885	1.596E-01	44
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3i-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8f3i-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) S466 insertion variant penicillin bound form from Enterococcus faecium	0.185	53	42	28	79	49	101	4.539E+00	43
LOKIASV2_1567_ESMFold_hypothetical_protein	5fi4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5fi4-assembly1.cif.gz_A Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model	0.100	316	242	177	492	716	985	1.142E-01	43
LOKIASV2_1567_ESMFold_hypothetical_protein	8exo-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8exo-assembly1.cif.gz_A Crystal structure of PI3K-alpha in complex with compound 19	0.105	316	237	177	492	622	887	1.674E-01	42
LOKIASV2_1567_ESMFold_hypothetical_protein	7tz7-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7tz7-assembly1.cif.gz_A PI3K alpha in complex with an inhibitor	0.113	314	238	179	492	706	974	1.933E-01	42
LOKIASV2_1567_ESMFold_hypothetical_protein	2jq5-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2jq5-assembly1.cif.gz_A Solution structure of RPA3114, a SEC-C motif containing protein from Rhodopseudomonas palustris; Northeast Structural Genomics Consortium target RpT5 / Ontario Center for Structural Proteomics target RP3097	0.114	80	67	142	221	40	116	2.215E+00	41
LOKIASV2_1567_ESMFold_hypothetical_protein	6g0k-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6g0k-assembly1.cif.gz_B Crystal structure of Enterococcus faecium D63r Penicillin-Binding protein 5 (PBP5fm)	0.192	57	44	26	81	48	104	6.048E+00	41
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3f-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8f3f-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) T485M variant apo form from Enterococcus faecium	0.170	46	37	36	81	59	104	6.048E+00	41
LOKIASV2_1567_ESMFold_hypothetical_protein	5sw8-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5sw8-assembly1.cif.gz_A Crystal structure of PI3Kalpha in complex with fragments 7 and 11	0.112	310	243	179	488	742	1016	1.596E-01	41
LOKIASV2_1567_ESMFold_hypothetical_protein	4j9a-assembly4.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	4j9a-assembly4.cif.gz_D Engineered Digoxigenin binder DIG10.3	0.061	48	44	34	81	60	107	6.048E+00	40
LOKIASV2_1567_ESMFold_hypothetical_protein	7jiu-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7jiu-assembly1.cif.gz_A HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 2F	0.098	297	226	196	492	635	886	1.089E-01	40
LOKIASV2_1567_ESMFold_hypothetical_protein	5xgh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5xgh-assembly1.cif.gz_A Crystal structure of PI3K complex with an inhibitor	0.090	358	283	133	490	663	974	2.340E-01	40
LOKIASV2_1567_ESMFold_hypothetical_protein	1wnh-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	1wnh-assembly1.cif.gz_A Crystal structure of mouse Latexin (tissue carboxypeptidase inhibitor)	0.084	182	153	36	217	35	202	6.433E-02	39
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3m-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8f3m-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) T485A variant with S466 insertion apo form from Enterococcus faecium	0.166	46	38	36	81	59	104	6.344E+00	39
LOKIASV2_1567_ESMFold_hypothetical_protein	7pg6-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7pg6-assembly1.cif.gz_A Crystal Structure of PI3Kalpha in complex with the inhibitor NVP-BYL719	0.100	316	244	177	492	728	999	2.231E-01	39
LOKIASV2_1567_ESMFold_hypothetical_protein	6g0k-assembly1.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6g0k-assembly1.cif.gz_C Crystal structure of Enterococcus faecium D63r Penicillin-Binding protein 5 (PBP5fm)	0.192	57	44	26	81	47	103	7.682E+00	38
LOKIASV2_1567_ESMFold_hypothetical_protein	6g88-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6g88-assembly2.cif.gz_B Crystal structure of Enterococcus Faecium D63r Penicillin-Binding protein 5 (PBP5fm)	0.192	57	44	26	81	48	104	8.453E+00	37
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3z-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8f3z-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) S422A variant apo form from Enterococcus faecium	0.170	46	37	36	81	58	103	8.867E+00	37
LOKIASV2_1567_ESMFold_hypothetical_protein	3ebt-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	3ebt-assembly1.cif.gz_A-2 Crystal structure of a ntf2-like protein of unknown function (bpss0132) from burkholderia pseudomallei k96243 at 1.30 A resolution	0.083	48	39	34	81	66	109	4.995E+00	36
LOKIASV2_1567_ESMFold_hypothetical_protein	2rgq-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2rgq-assembly1.cif.gz_A Crystal structure of a protein of unknown function with a cystatin-like fold (npun_r3134) from nostoc punctiforme pcc 73102 at 1.80 A resolution	0.120	48	41	174	221	67	114	6.048E+00	36
LOKIASV2_1567_ESMFold_hypothetical_protein	3f7s-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	3f7s-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF A NTF2-LIKE PROTEIN OF UNKNOWN FUNCTION (PP_4556) FROM PSEUDOMONAS PUTIDA KT2440 AT 2.11 A RESOLUTION	0.092	52	46	170	221	64	115	6.344E+00	36
LOKIASV2_1567_ESMFold_hypothetical_protein	8f3q-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	8f3q-assembly1.cif.gz_A Crystal structure of Penicillin Binding Protein 5 (PBP5) Y460A variant apo form from Enterococcus faecium	0.177	44	35	36	79	58	101	9.301E+00	36
LOKIASV2_1567_ESMFold_hypothetical_protein	2rd0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2rd0-assembly1.cif.gz_A Structure of a human p110alpha/p85alpha complex	0.117	306	225	177	482	718	973	4.154E-01	36
LOKIASV2_1567_ESMFold_hypothetical_protein	6mkg-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6mkg-assembly1.cif.gz_A Crystal structure of penicillin binding protein 5 (PBP5) from Enterococcus faecium in the benzylpenicilin-bound form	0.166	46	38	36	81	58	103	9.301E+00	35
LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_G-2	LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_G-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CaMKII alpha hub bound to 5-HDC	0.108	45	38	36	79	62	106	3.749E+00	34
LOKIASV2_1567_ESMFold_hypothetical_protein	4kz1-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	4kz1-assembly1.cif.gz_A-2 Crystal structure of the soluble domain of VirB8 from Bartonella grahamii	0.067	89	78	130	218	21	105	3.749E+00	34
LOKIASV2_1567_ESMFold_hypothetical_protein	6isl-assembly1.cif.gz_B-2	LOKIASV2_1567_ESMFold_hypothetical_protein	6isl-assembly1.cif.gz_B-2 SnoaL-like cyclase XimE with its product xiamenmycin B	0.139	43	35	40	81	61	103	8.867E+00	33
LOKIASV2_1567_ESMFold_hypothetical_protein	4lso-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4lso-assembly1.cif.gz_A Crystal structure of the soluble domain of a Type IV secretion system protein VirB8 from Bartonella quintana Toulouse	0.070	89	78	130	218	24	108	3.096E+00	33
LOKIASV2_1567_ESMFold_hypothetical_protein	4waf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4waf-assembly1.cif.gz_A Crystal Structure of a novel tetrahydropyrazolo[1,5-a]pyrazine in an engineered PI3K alpha	0.101	314	244	179	492	723	994	2.575E-01	33
LOKIASV2_1567_ESMFold_hypothetical_protein	7pqh-assembly1.cif.gz_K	LOKIASV2_1567_ESMFold_hypothetical_protein	7pqh-assembly1.cif.gz_K Cryo-EM structure of Saccharomyces cerevisiae TOROID (TORC1 Organized in Inhibited Domains).	0.129	323	267	175	482	815	1137	2.455E-01	33
LOKIASV2_1567_ESMFold_hypothetical_protein	4qjv-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4qjv-assembly1.cif.gz_B The X-ray crystal structure of Rpo3/Rpo11 heterodimer of euryarchaeal RNA polymerase from Thermococcus kodakarensis	0.093	118	83	43	160	2	94	3.933E+00	32
LOKIASV2_1567_ESMFold_hypothetical_protein	6zgn-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6zgn-assembly1.cif.gz_A Crystal structure of VirB8-like OrfG central domain of Streptococcus thermophilus ICESt3; a putative assembly factor of a gram positive conjugative Type IV secretion system.	0.089	84	68	146	221	5	88	3.248E+00	32
LOKIASV2_1567_ESMFold_hypothetical_protein	6wf4-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6wf4-assembly1.cif.gz_A Crystal Structure of TerC Co-crystallized with Polyporic Acid	0.127	47	37	175	221	67	109	6.655E+00	32
LOKIASV2_1567_ESMFold_hypothetical_protein	2z77-assembly2.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	2z77-assembly2.cif.gz_D X-ray crystal structure of RV0760c from Mycobacterium tuberculosis in complex with estradiol-17beta-hemisuccinate	0.086	46	39	36	81	68	111	4.762E+00	32
LOKIASV2_1567_ESMFold_hypothetical_protein	4nhf-assembly3.cif.gz_E	LOKIASV2_1567_ESMFold_hypothetical_protein	4nhf-assembly3.cif.gz_E Crystal structure of the soluble domain of TrwG Type IV secretion machinery from Bartonella grahamii	0.149	124	87	95	218	7	109	1.919E+00	32
LOKIASV2_1567_ESMFold_hypothetical_protein	8ecp-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	8ecp-assembly1.cif.gz_B R16A PA0709 with BME modifications	0.121	80	68	74	151	2	81	8.058E+00	31
LOKIASV2_1567_ESMFold_hypothetical_protein	6of8-assembly1.cif.gz_G-2	LOKIASV2_1567_ESMFold_hypothetical_protein	6of8-assembly1.cif.gz_G-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CamKII-alpha hub domain	0.109	62	49	18	79	52	107	3.096E+00	31
LOKIASV2_1567_ESMFold_hypothetical_protein	6of8-assembly1.cif.gz_D-2	LOKIASV2_1567_ESMFold_hypothetical_protein	6of8-assembly1.cif.gz_D-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CamKII-alpha hub domain	0.127	55	45	28	79	56	110	5.765E+00	31
LOKIASV2_1567_ESMFold_hypothetical_protein	5if6-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5if6-assembly2.cif.gz_B Structure of a computationally designed 17-OHP binder	0.108	46	38	36	81	68	111	6.344E+00	31
LOKIASV2_1567_ESMFold_hypothetical_protein	4eoh-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4eoh-assembly1.cif.gz_B Crystal Structure of Human PL Kinase with bound Theophylline	0.090	44	37	180	221	181	224	7.323E+00	31
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_F	LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_F Crystal structure of the human CaMKII-alpha hub	0.130	45	37	36	79	61	105	6.655E+00	30
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_B Crystal structure of the human CaMKII-alpha hub	0.078	50	42	175	221	64	113	4.762E+00	30
LOKIASV2_1567_ESMFold_hypothetical_protein	5ier-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	5ier-assembly3.cif.gz_C Structure of a computationally designed 17-OHP binder	0.104	46	40	36	81	66	111	8.453E+00	30
LOKIASV2_1567_ESMFold_hypothetical_protein	2p9p-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	2p9p-assembly1.cif.gz_D Crystal Structure of bovine Arp2/3 complex co-crystallized with ADP	0.131	222	162	43	264	29	215	6.388E-01	30
LOKIASV2_1567_ESMFold_hypothetical_protein	2yxu-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	2yxu-assembly1.cif.gz_B Human Pyridoxal Kinase	0.090	44	37	180	221	182	225	8.058E+00	30
LOKIASV2_1567_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_G	LOKIASV2_1567_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_G CaMKII alpha-30 Cryo-EM reconstruction	0.109	54	44	172	221	62	115	5.240E+00	29
LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_F-2	LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_F-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CaMKII alpha hub bound to 5-HDC	0.148	53	43	28	79	57	109	5.240E+00	29
LOKIASV2_1567_ESMFold_hypothetical_protein	4bqu-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4bqu-assembly2.cif.gz_B Japanin from Rhipicephalus appendiculatus bound to cholesterol: Orthorhombic crystal form	0.117	113	95	170	282	20	128	2.438E+00	29
LOKIASV2_1567_ESMFold_hypothetical_protein	3keu-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3keu-assembly1.cif.gz_B Crystal Structure of Human PL Kinase with bound PLP and ATP	0.090	44	37	180	221	181	224	8.867E+00	29
LOKIASV2_1567_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_A Hexadecameric hub domain of CaMKII beta	0.094	52	43	173	221	56	107	5.765E+00	28
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_E	LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_E Crystal structure of the human CaMKII-alpha hub	0.120	49	40	36	81	62	110	5.765E+00	28
LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_A Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CaMKII alpha hub bound to 5-HDC	0.108	44	37	36	79	70	112	6.344E+00	28
LOKIASV2_1567_ESMFold_hypothetical_protein	4mei-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	4mei-assembly1.cif.gz_A-2 Crystal structure of a VirB8 Type IV secretion system machinery soluble domain from Bartonella tribocorum	0.080	87	75	132	218	23	105	3.933E+00	28
LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_E-2	LOKIASV2_1567_ESMFold_hypothetical_protein	7rec-assembly1.cif.gz_E-2 Structure of Thr354Asn, Glu355Gln, Thr412Asn, Ile414Met, Ile464His, and Phe467Met mutant human CaMKII alpha hub bound to 5-HDC	0.078	48	42	175	221	64	111	6.981E+00	27
LOKIASV2_1567_ESMFold_hypothetical_protein	1hkx-assembly1.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	1hkx-assembly1.cif.gz_C Crystal structure of calcium/calmodulin-dependent protein kinase	0.097	139	97	83	221	16	123	1.830E+00	27
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_A-2	LOKIASV2_1567_ESMFold_hypothetical_protein	5ig3-assembly1.cif.gz_A-2 Crystal structure of the human CaMKII-alpha hub	0.108	44	37	36	79	84	126	8.867E+00	27
LOKIASV2_1567_ESMFold_hypothetical_protein	2lqj-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2lqj-assembly1.cif.gz_A Solution structure of the C-terminal domain of the MgtC protein from Mycobacterium tuberculosis	0.078	99	71	47	145	1	78	8.453E+00	26
LOKIASV2_1567_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6w4o-assembly1.cif.gz_C CaMKII alpha-30 Cryo-EM reconstruction	0.130	45	37	36	79	64	108	9.757E+00	26
LOKIASV2_1567_ESMFold_hypothetical_protein	7ury-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7ury-assembly1.cif.gz_A Tetradecameric hub domain of CaMKII beta	0.089	55	46	170	221	58	112	6.655E+00	26
LOKIASV2_1567_ESMFold_hypothetical_protein	3fhy-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3fhy-assembly1.cif.gz_B Crystal structure of D235N mutant of human pyridoxal kinase	0.112	71	55	180	242	181	251	5.496E+00	26
LOKIASV2_1567_ESMFold_hypothetical_protein	4en4-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	4en4-assembly1.cif.gz_B Crystal Structure of the Ternary Human PL Kinase-Ginkgotoxin-MgATP Complex	0.112	71	55	180	242	182	252	5.496E+00	26
LOKIASV2_1567_ESMFold_hypothetical_protein	6x1k-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6x1k-assembly1.cif.gz_A Solution NMR structure of de novo designed TMB2.3	0.102	83	54	44	126	57	117	4.327E+00	24
LOKIASV2_1567_ESMFold_hypothetical_protein	2ux0-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	2ux0-assembly1.cif.gz_A Structure of the oligomerisation domain of calcium-calmodulin dependent protein kinase II gamma	0.109	54	44	172	221	71	124	9.757E+00	24
LOKIASV2_1567_ESMFold_hypothetical_protein	7sjy-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7sjy-assembly2.cif.gz_B Crystal structure of Clostridium thermocellum RsgI9 S1C-NTF2 bi-domain	0.058	180	167	44	221	122	301	1.309E+00	24
LOKIASV2_1567_ESMFold_hypothetical_protein	5ig4-assembly1.cif.gz_F	LOKIASV2_1567_ESMFold_hypothetical_protein	5ig4-assembly1.cif.gz_F Crystal structure of N. vectensis CaMKII-A hub	0.125	62	51	18	79	54	112	9.757E+00	23
LOKIASV2_1567_ESMFold_hypothetical_protein	6qle-assembly1.cif.gz_P	LOKIASV2_1567_ESMFold_hypothetical_protein	6qle-assembly1.cif.gz_P Structure of inner kinetochore CCAN complex	0.068	181	135	36	216	56	201	2.324E+00	23
LOKIASV2_1567_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7urz-assembly1.cif.gz_B Hexadecameric hub domain of CaMKII beta	0.104	62	54	18	79	49	109	6.344E+00	22
LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly1.cif.gz_D 1.98A STRUCTURE OF THIOPHENE1 WITH S.AUREUS DNA GYRASE AND DNA	0.118	303	214	191	493	420	663	3.960E-01	22
LOKIASV2_1567_ESMFold_hypothetical_protein	5aii-assembly1.cif.gz_H	LOKIASV2_1567_ESMFold_hypothetical_protein	5aii-assembly1.cif.gz_H Discovery and characterization of thermophilic limonene-1,2-epoxide hydrolases from hot spring metagenomic libraries. CH55-sample-PEG complex	0.085	45	38	175	219	60	102	6.344E+00	21
LOKIASV2_1567_ESMFold_hypothetical_protein	5gyd-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5gyd-assembly1.cif.gz_B Crystal Structure of Mdm12	0.103	102	67	144	219	16	117	3.933E+00	20
LOKIASV2_1567_ESMFold_hypothetical_protein	7z7p-assembly3.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	7z7p-assembly3.cif.gz_C Structure of the fluorescent protein NeonCyan0.95 at pH 5.6	0.048	98	84	40	137	137	225	3.749E+00	20
LOKIASV2_1567_ESMFold_hypothetical_protein	6qlf-assembly1.cif.gz_P	LOKIASV2_1567_ESMFold_hypothetical_protein	6qlf-assembly1.cif.gz_P Structure of inner kinetochore CCAN complex with mask1	0.076	181	134	36	216	42	187	3.574E+00	20
LOKIASV2_1567_ESMFold_hypothetical_protein	2w2c-assembly1.cif.gz_L	LOKIASV2_1567_ESMFold_hypothetical_protein	2w2c-assembly1.cif.gz_L STRUCTURE OF THE TETRADECAMERIC OLIGOMERISATION DOMAIN OF CALCIUM- CALMODULIN DEPENDENT PROTEIN KINASE II DELTA	0.129	141	102	81	221	1	118	6.048E+00	19
LOKIASV2_1567_ESMFold_hypothetical_protein	7r6q-assembly1.cif.gz_N	LOKIASV2_1567_ESMFold_hypothetical_protein	7r6q-assembly1.cif.gz_N State E2 nucleolar 60S ribosome biogenesis intermediate - Foot region model	0.077	89	63	48	136	53	121	4.327E+00	19
LOKIASV2_1567_ESMFold_hypothetical_protein	3s1t-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3s1t-assembly1.cif.gz_B Structure of the regulatory domain of aspartokinase (Rv3709c; AK-beta) in complex with threonine from Mycobacterium tuberculosis	0.063	173	102	93	265	30	139	3.933E+00	19
LOKIASV2_1567_ESMFold_hypothetical_protein	5npp-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	5npp-assembly1.cif.gz_D 2.22A STRUCTURE OF THIOPHENE2 AND GSK945237 WITH S.AUREUS DNA GYRASE AND DNA	0.103	302	217	191	492	418	660	9.825E-01	19
LOKIASV2_1567_ESMFold_hypothetical_protein	3cqn-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3cqn-assembly2.cif.gz_B Crystal Structure of the Lipocalin domain of Violaxanthin de-epoxidase (VDE) at pH7	0.089	126	110	175	296	21	146	5.765E+00	18
LOKIASV2_1567_ESMFold_hypothetical_protein	4zbl-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4zbl-assembly1.cif.gz_A Phototoxic fluorescent protein mKillerOrange	0.074	98	84	34	131	134	225	8.867E+00	18
LOKIASV2_1567_ESMFold_hypothetical_protein	5cdp-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	5cdp-assembly1.cif.gz_A 2.45A structure of etoposide with S.aureus DNA gyrase and DNA	0.115	302	214	191	492	229	471	1.134E+00	18
LOKIASV2_1567_ESMFold_hypothetical_protein	2xct-assembly1.cif.gz_D	LOKIASV2_1567_ESMFold_hypothetical_protein	2xct-assembly1.cif.gz_D The twinned 3.35A structure of S. aureus Gyrase complex with Ciprofloxacin and DNA	0.127	303	212	191	493	415	658	1.585E+00	18
LOKIASV2_1567_ESMFold_hypothetical_protein	2w2c-assembly1.cif.gz_K	LOKIASV2_1567_ESMFold_hypothetical_protein	2w2c-assembly1.cif.gz_K STRUCTURE OF THE TETRADECAMERIC OLIGOMERISATION DOMAIN OF CALCIUM- CALMODULIN DEPENDENT PROTEIN KINASE II DELTA	0.113	140	97	82	221	6	115	8.453E+00	17
LOKIASV2_1567_ESMFold_hypothetical_protein	7z7o-assembly2.cif.gz_D-2	LOKIASV2_1567_ESMFold_hypothetical_protein	7z7o-assembly2.cif.gz_D-2 Structure of the fluorescent protein NeonCyan0.95 at pH 7.5	0.048	84	67	44	127	136	206	6.344E+00	17
LOKIASV2_1567_ESMFold_hypothetical_protein	2ajp-assembly3.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	2ajp-assembly3.cif.gz_B Crystal structure of a human pyridoxal kinase	0.099	138	118	111	242	113	250	7.682E+00	17
LOKIASV2_1567_ESMFold_hypothetical_protein	6fqs-assembly1.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	6fqs-assembly1.cif.gz_C 3.11A complex of S.Aureus gyrase with imidazopyrazinone T3 and DNA	0.114	395	304	98	492	127	470	7.030E-01	17
LOKIASV2_1567_ESMFold_hypothetical_protein	6z1a-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	6z1a-assembly1.cif.gz_B Ternary complex of Staphylococcus aureus DNA gyrase with AMK12 and DNA	0.098	302	218	191	492	417	659	2.438E+00	17
LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly1.cif.gz_B 1.98A STRUCTURE OF THIOPHENE1 WITH S.AUREUS DNA GYRASE AND DNA	0.118	303	214	191	493	419	662	1.744E+00	17
LOKIASV2_1567_ESMFold_hypothetical_protein	4bul-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	4bul-assembly1.cif.gz_A Novel hydroxyl tricyclics (e.g. GSK966587) as potent inhibitors of bacterial type IIA topoisomerases	0.110	302	215	191	492	420	662	2.215E+00	17
LOKIASV2_1567_ESMFold_hypothetical_protein	7syf-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7syf-assembly1.cif.gz_A Reconstruction of full-length Prex-1 (PtdIns(3,4,5)P3-dependent Rac Exchanger 1)	0.092	441	264	50	490	745	1036	8.512E-01	17
LOKIASV2_1567_ESMFold_hypothetical_protein	7mvs-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	7mvs-assembly1.cif.gz_B DNA gyrase complexed with uncleaved DNA and Compound 7 to 2.6A resolution	0.127	302	211	191	492	422	664	2.557E+00	16
LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly2.cif.gz_b	LOKIASV2_1567_ESMFold_hypothetical_protein	5npk-assembly2.cif.gz_b 1.98A STRUCTURE OF THIOPHENE1 WITH S.AUREUS DNA GYRASE AND DNA	0.124	303	213	191	493	422	665	3.248E+00	15
LOKIASV2_1567_ESMFold_hypothetical_protein	3rfz-assembly3.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3rfz-assembly3.cif.gz_B Crystal structure of the FimD usher bound to its cognate FimC:FimH substrate	0.065	171	128	48	218	438	575	4.125E+00	15
LOKIASV2_1567_ESMFold_hypothetical_protein	2gbx-assembly1.cif.gz_F	LOKIASV2_1567_ESMFold_hypothetical_protein	2gbx-assembly1.cif.gz_F Crystal Structure of Biphenyl 2,3-Dioxygenase from Sphingomonas yanoikuyae B1 Bound to Biphenyl	0.081	132	110	86	217	18	138	9.301E+00	14
LOKIASV2_1567_ESMFold_hypothetical_protein	2dd9-assembly2.cif.gz_C	LOKIASV2_1567_ESMFold_hypothetical_protein	2dd9-assembly2.cif.gz_C A mutant of GFP-like protein from Chiridius poppei	0.057	91	82	41	131	126	213	7.323E+00	14
LOKIASV2_1567_ESMFold_hypothetical_protein	3e8j-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3e8j-assembly1.cif.gz_B Coproporphyrinogen III oxidase from Leishmania naiffi	0.028	232	125	11	242	16	145	6.048E+00	13
LOKIASV2_1567_ESMFold_hypothetical_protein	6qx2-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	6qx2-assembly1.cif.gz_A 3.4A structure of benzoisoxazole 3 with S.aureus DNA gyrase and DNA	0.125	302	210	191	492	227	467	4.762E+00	13
LOKIASV2_1567_ESMFold_hypothetical_protein	7fvt-assembly1.cif.gz_A	LOKIASV2_1567_ESMFold_hypothetical_protein	7fvt-assembly1.cif.gz_A Crystal Structure of S. aureus gyrase in complex with 6-[5-[2-[(4-chloro-2,3-dihydro-1H-inden-2-yl)methylamino]ethyl]-2-oxo-1,3-oxazolidin-3-yl]-4H-pyrido[3,2-b][1,4]oxazin-3-one	0.131	301	209	192	492	418	659	4.327E+00	13
LOKIASV2_1567_ESMFold_hypothetical_protein	5npp-assembly1.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	5npp-assembly1.cif.gz_B 2.22A STRUCTURE OF THIOPHENE2 AND GSK945237 WITH S.AUREUS DNA GYRASE AND DNA	0.115	302	214	191	492	418	660	5.765E+00	13
LOKIASV2_1567_ESMFold_hypothetical_protein	3bs0-assembly2.cif.gz_B	LOKIASV2_1567_ESMFold_hypothetical_protein	3bs0-assembly2.cif.gz_B Crystal structure of the P. putida toluene transporter TodX	0.093	183	156	36	218	92	264	6.981E+00	12
